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Zusammenfassung 
 
Die Gene, die für rRNA kodieren (rDNA), liegen in Säugerzellen in mehreren 
hundert Kopien vor, von denen etwa die Hälfte transkriptionell aktiv, die andere 
Hälfte inaktiv ist. Aktive und inaktive rDNA Kopien weisen eine 
unterschiedliche Chromatinstruktur auf. Aktive Gene liegen in ‚offener’ 
euchromatischer Konfiguration vor, während inaktive Gene eine kompakte 
heterochromatische Struktur aufweisen. Nukleosomen an aktiven rDNA 
Promotoren sind durch spezifische Histonmodifikationen charakterisiert, die 
sich von Histonmodifikationen an inaktiven Genen unterscheiden. So ist z.B. 
Histon H3 am Promotor aktiver Gene an Lysin 4 methyliert (H3K4me), 
während Histon H3 an inaktiven Gene an Lysin 9 methyliert (H3K9me) ist. Das 
Gleichgewicht zwischen H3K4me und H3K9me wird durch das koordinierte 
Zusammenspiel von verschiedenen Histon-Methyltransferasen und -
Demethylasen etabliert und aufrechterhalten. Für verschiedene Histon-H3K9-
Methyltransferasen wie G9a, SETDB1 und Suv39H1 konnte gezeigt werden, 
dass sie die Chromatinstruktur von rDNA modulieren. Enzyme, die 
reprimierende Methylgruppen von H3K9 am rDNA Promotor entfernen, sind 
bislang unbekannt. In der vorliegenden Arbeit wird die Funktion von zwei 
putativen Histon-Demethylasen, PHF2 und PHF8, charakterisiert. 
Sowohl PHF2 als auch PHF8 lokalisieren in Nukleoli und sind mit 
aktiven rRNA Genen assoziiert. Depletierungs- und Überexpressions-
Experimente demonstrieren, dass PHF2 und PHF8 die Pol I Transkription 
aktivieren. Die transkriptionelle Aktivierung hängt von der Präsenz eines 
funktionellen PHD-Fingers und der JmjC-Domäne ab. PHF2 und PHF8 werden 
durch Interaktion mit der Pol I Transkriptionsmaschinerie an die rDNA 
rekrutiert. Zusätzlich binden die PHD-Finger von PHF2 und PHF8 an 
H3K4me3, ein Befund der die Bindung von PHF2 und PHF8 an aktive rRNA 
Gene unterstützt. Wird PHF8 durch siRNA depletiert, wird H3K9 am rDNA 
Promotor verstärkt methyliert. Dies weist darauf hin, dass PHF8 eine 
H3K9me1/2 Demethylase ist. Im Gegensatz dazu zeigt PHF2 keine Histon-
demethylierende Aktivität, sondern scheint der H3K4 Demethylase KDM2B 
entgegenzuwirken. Mutationen in dem humanen PHF8 Gen korrelieren mit der 
Erbkrankheit XLMR (X-linked mental retardation). Eine mit XLMR-assoziierte 
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Punktmutation in der JmjC-Domäne von PHF8 (F279S) verhindert sowohl die 
Interaktion mit der Pol I-Transkriptionsmaschinerie als auch die nukleoläre 
Lokalisation und die PHF8-vermittelte Aktivierung der prä-rRNA. Es ist daher 
sehr wahrscheinlich, dass Inaktivierung von PHF8 zur ineffizienten rDNA 
Transkription führt und dies zur Entstehung von XLMR beiträgt. 
Die vorliegenden Ergebnisse zeigen eine wichtige Rolle von PHF2 und 
PHF8 in der epigenetischen Regulation von rRNA Genen. Diese Regulation ist 
essentiell für die effiziente Transkription von rRNA Genen, und deren 
Dysregulation führt zu schweren genetischen Krankheiten. 
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Summary 
 
In mammalian cells, actively transcribed rRNA genes (rDNA) exist in a 
euchromatic configuration, whereas silent rDNA repeats form a 
heterochromatic structure. A hallmark of active rDNA is methylation of histone 
H3 lysine K4 (H3K4me), while silent genes are characterized by methylation of 
histone H3 lysine K9 (H3K9me). The balance between H3K4me and H3K9me 
is established and maintained by the coordinated interplay of different histone 
methyltransferases and demethylases. Several histone H3K9 methyltransferases 
such as G9a, SETDB1 and Suv39H1, have been shown to modulate the 
chromatin structure of rRNA genes. However, the enzymes that remove 
repressive methyl groups from H3K9 at the rDNA promoter are yet unknown. 
In the present study, the function of two putative Jumonji-C (JmjC) domain-
containing histone demethylases PHF2 (PHD finger protein 2) and PHF8 (PHD 
finger protein 8) has been characterized. 
Both PHF2 and PHF8 localize to nucleoli and are associated with 
active rRNA genes. Gain-of-function and loss-of-function experiments 
demonstrate that PHF2 and PHF8 activate rDNA transcription. Transcriptional 
activation depends on the presence of a functional PHD finger and the JmjC 
domain. Recruitment of PHF2 and PHF8 to rDNA is mediated by the 
interaction with the RNA polymerase I (Pol I) transcription machinery. In 
addition, the PHD fingers of PHF2 and PHF8 bind to the euchromatic histone 
mark, H3K4me3, which may facilitate the association of both proteins with 
active rDNA. Depletion of PHF8 leads to increased levels of the repressive 
marks H3K9me1 and H3K9me2 (H3K9me1/2) at the rDNA promoter, 
suggesting that PHF8 demethylates H3K9me1/2. In contrast, PHF2 shows no 
histone demethylase activity on itself but appears to antagonize a transcriptional 
repressor, the H3K4me3 demethylase KDM2B. The association of PHF2 with 
rDNA depends on PHF8, indicating that PHF2 and PHF8 function as a complex 
that is able to remove H3K9me1/2 and to maintain H3K4me3 at active rDNA 
repeats.  
Mutations in the human PHF8 gene are associated with an inherited 
disease termed X-linked mental retardation (XLMR). As demonstrated in this 
study, an XLMR-associated point mutation in the JmjC domain of PHF8 
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(F279S) impairs the interaction with the Pol I transcription machinery, the 
nucleolar localization and PHF8-dependent transcriptional activation. Thus, 
impairment of PHF8-mediated activation of rDNA transcription might 
contribute to the development of XLMR.  
Together, the results uncover an important function of PHF2 and PHF8 
in nucleoli, adding a new layer of epigenetic regulation of rRNA genes. This 
regulation is vital for proper rRNA synthesis and its disruption is likely to cause 
severe diseases in humans.  
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1. Introduction 
 
1.1.  Epigenetic regulation of gene expression 
 
The genome of a diploid human cell contains approximately 3 billion base pairs 
of DNA, which is about 2 meters in length. To fit the large genome into the 
microscopic space of eukaryotic nucleus, DNA is compacted by histones to 
form chromatin. Chromatin is the physiological template for all kinds of DNA-
dependent processes such as transcription, replication, recombination, and DNA 
repair. Histones are a family of positively charged proteins, termed histone H1, 
H2A, H2B, H3 and H4. As DNA is negatively charged, histones bind to DNA 
very tightly. The fundamental unit of chromatin is the nucleosome, an octamer 
containing two of each of the core histones (H2A, H2B, H3, H4) wrapped 
around 146 base pairs of DNA. The linker histone H1 binds the nucleosome at 
the entry and exit sites of the DNA, thus locking the DNA into place and 
allowing the formation of higher order structure.  
Like other DNA-related metabolic processes, all stages of transcription 
from initiation to termination are affected by the packaging of DNA into 
chromatin. The presence of nucleosomes poses barriers to RNA polymerases. It 
is therefore important for cells to have means of ‘‘opening’’ chromatin and/or 
removing histones transiently to permit transcription. There are two major 
mechanisms by which chromatin becomes more accessible. First, histones can 
be modified by addition of acetyl or phosphate groups that reduce the DNA-
histone interaction; second, histones can be displaced by chromatin remodeling 
complexes, thereby exposing underlying DNA sequences to DNA binding 
proteins.  
The core histones are predominantly globular except for their 
unstructured N-terminal “tails”. One of the most important features of histones 
is that histone tails and to a less extent also globular domains are subjected to a 
wide range of posttranslational modifications. The most common modifications 
include methylation, acetylation and ubiquitylation of lysine (K) residues; 
methylation of arginine (R) residues; and phosphorylation of serine (S) and 
threonine (T) residues (Fig. 1.1). As most, if not all, histone modifications are 
reversible, this post-translational histone marking system represents a 
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fundamental regulatory mechanism for chromatin function (Jenuwein and Allis 
2001). Histone modifications regulate transcription by affecting higher-order 
chromatin structure or by recruiting effector proteins that further modify 
chromatin. While acetylation and phosphorylation increase the negative charge 
of histones and therefore reduce the DNA-histone interaction, methylation does 
not influence the net charge of histones, and hence, has no effect on DNA-
histone interaction. Instead, histone methylations function as recognition marks 
for effector proteins.  
 
 
Figure 1.1. Common posttranslational modifications in histone H3 
A scheme outlines the common posttranslational modifications in histone H3, including 
acetylation (ac), methylation (me), and phosphorylation (ph). The numbers below 
residues indicate the positions of individual amino acids. Figure from Bhaumik et al. 
2007. 
 
There are two distinct chromatin structures, transcriptional silent 
heterochomatin and active euchromatin, which are demonstrated by a distinct 
set of chromatin modifications. Histone modifications like acetylation and 
phosphorylation are generally related to active transcription. Methylation and 
ubiquitylation of lysine and arginine methylation can both activate and repress 
transcription, depending on the particular residue that is modified. The 
transcriptional outcome of certain histone modification is dependent on the 
context, i.e. the information has to be decoded by downstream effector proteins. 
Effector proteins are recruited to certain chromatin areas by recognizing specific 
histone modifications. After recruitment, these effector proteins either modify 
the chromatin by themselves or recruit other factors that directly impact 
chromatin structure. An increasingly growing number of chromatin-recognition 
motifs have been identified. For example, histone methylation is recognized by 
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PHD-, chromo-, tudor- and MBT-domains. Acetylation of histones is 
recognized by bromodomains, and phosphorylation by a domain within 14-3-3 
proteins (Taverna et al. 2007).  
Covalent modifications do not only occur on histones, but also on 
DNA. In mammalian cells, DNA can be methylated at cytosine residues that 
reside in CpG dinucleotide sequences. The majority of CpGs are methylated in 
mammals, whereas unmethylated CpGs are grouped in clusters, termed “CpG 
islands”, which are present in the 5’ regulatory regions of many genes (Cedar 
and Bergman 2009). DNA methylation usually results in heritable 
transcriptional silencing at least partly by preventing association of general 
transcription factors with gene promoters. Like histone methylation, the 
methylation state of CpGs is recognized by specific proteins. Methylated CpG 
dinucleotides are recognized by methyl-CpG binding domain (MBD) 
containing-proteins, such as MBD1-MBD4 and MECP2, whereas the CXXC 
zinc-finger domain specifically binds to unmethylated CpG-rich regions (Voo et 
al. 2000).  
Generally, nucleosomes present a barrier for the transcription 
machinery to pass through DNA. To overcome this, a family of chromatin 
remodeling factors that are able to alter the histone-DNA contacts at the 
expense of ATP-hydrolysis, has evolved. The dynamics of nucleosome 
remodeling regulate DNA accessibility that is key to proper gene regulation. For 
instance, a positioned nucleosome directly upstream of the transcription start 
site of many genes has to be repositioned or evicted to expose regulatory 
elements to transcription factors upon gene activation (Henikoff  2008). 
 
1.2.  Establishment and interpretation of histone lysine                    
methylation 
 
1.2.1.  Histone lysine methylation and transcription 
 
Histone lysine methylation has been shown to play important roles in 
maintaining genome integrity, transcription and epigenetic memory (Martin and 
Zhang 2005). Methylation occurs on several lysine residues in the N-terminal 
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tails of histone H3 and H4 and in the globular domain of histones as well. There 
are three different methylation states of lysine residues: mono-, di-, or trimethyl. 
Each methylation state is often associated with a distinct biological outcome. 
Consequently, protein modules that bind methylated lysines should be selective 
not only towards a given lysine residue but also for its methylation state. The 
same holds true for enzymes that catalyze the transfer or removal of the methyl 
groups. Thus, a complex regulatory network establishes a specific pattern of 
histone lysine methylation (Kustatscher and Ladurner 2007). With the exception 
of methylation of H3K79, histone lysine methylations are catalyzed by a family 
of SET domain-containing proteins (Qian and Zhou 2006). In contrast to histone 
acetyltransferases, which have a broad substrate specificity, most histone 
methyltransferases only modify a defined lysine residue to a specific 
methylation state.  
Histone methylation can both activate or repress transcription, 
depending on the particular lysine residue that is methylated. In most cases, 
methylation on histone H3K4, H3K36 and H3K79 is associated with 
euchromatic regions, whereas H3K9me, H3K27me and H4K20me are found in 
heterochromatin. However, there are increasing evidences showing that the 
transcriptional outcome of a particular histone methylation is context dependent, 
relying on both the localization of this modification and the effector proteins 
that recognize the modification (Li et al. 2007; Kouzarides 2007). Different 
histone methylaton marks exhibit a distinct localized pattern within a gene, with 
preference either at the enhancer region, the core promoter or the gene body. 
Indeed, the location of a given modification is tightly regulated and is crucial 
for its effect on transcription. For example, methylation at H3K36 or H3K9 has 
a positive effect when it is localized within the coding region of certain gene but 
has a negative effect when it is present in the promoter (Landry et al. 2003; 
Vakoc et al. 2005). Moreover, histone lysine methylation appears to function as 
a nucleation site for effector proteins (Taverna et al. 2007). These effector 
proteins recognize specific histone lysine methylation and impact chromatin by 
themselves or by recruiting downstream proteins, which either activate or 
repress gene expression. For instance, BPTF, the largest subunit of nucleosome 
remodeling factor (NURF), binds to chromatin by recognizing H3K4me3 via its 
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PHD finger, leading to activation of Hox gene expression (Wysocka et al. 
2006).  
1.2.2.  Histone demethylases  
 
Similar to DNA methylation, methylation of histones has been regarded as 
irreversible because of the high thermodynamic stability of the N-CH3 bond. 
However, the recent identifications of histone demethylases have shown that 
histone methylation is reversible and dynamically regulated like other histone 
modifications (Shi et al. 2004; Yamane et al. 2006; reviewed by Cloos et al. 
2008). So far, two groups of histone demethylases have been characterized, 
LSD1 and a family of Jumonji (JmjC) domain-containing proteins. LSD1 
removes methyl group through a flavin adenine dinucleotide (FAD)-dependent 
amine oxidase reaction (Fig. 1.2, upper panel). However, as this reaction 
requires a protonated methyl ε-ammonium group for oxidation, LSD1 is not 
able to catalyze the demethylation of trimethylated lysine residues. Unlike 
LSD1, the JmjC domain-containing histone demethylases are able to remove all 
three methyl groups from histones. The JmjC domain cooperates with cofactor 
iron Fe(II) and α-ketoglutarate (αKG) to produce highly reactive oxoferryl 
species that hydroxylate the methylated substrate, allowing spontaneous loss of 
the methyl group as formaldehyde (Fig. 1.2, lower panel).  
The JmjC domain is structurally conserved, each of the two layered 
β sheets containing four antiparellel β strands that produce the typical jellyroll-
like structure (Fig. 1.3). A highly conserved His-X-ASP/GLU-Xn-His motif (X: 
any amino acid; Xn: various number of amino acid in between) supplies three 
chelating positions for the iron. αKG interacts with the iron and is further 
stabilized by the interaction with two additional conserved residues 
(Phe/Thr/Tyr for the first and Lys for the second amino acid). All these residues 
are conserved in the JmjC domains of active histone demethylases and mutation 
of these critical residues results in loss of demethylation activity.  
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Figure 1.2. The mechanisms of removing methyl group by demethylases 
(Upper) LSD1 mediates histone demethylation through an amine oxidation reaction using 
FAD as a cofactor. Loss of the methyl group from mono-methyl lysine occurs through an 
imine intermediate, which is hydrolysed to form formadelhyde. (Lower) The JmjC 
domain-containing proteins use iron and αKG as cofactors in an oxidative demethylation 
reaction that produces hydroxymethyl-lysine, succinate and CO2 as reaction products. The 
hydroxymethyl group is then spontaneously lost as formaldehyde. Figure from Klose and 
Zhang. 2007. 
 
 
Figure 1.3. Structure of the 
JmjC domain of KDM4A 
The scheme demonstrates the 
structure of the JmjC domain of the 
histone H3K9 demethylase 
KDM4A. Residues that are involved 
in the interactions with the cofactors 
iron (His188, Glu190 and His276) 
and the αKG molecule (Tyr132, 
Asn198, and Lys206) are displayed 
and labeled. Figure from Chen et al. 
2006. 
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There are about 27 different JmjC domain-containing proteins encoded 
in the human genome, and 15 of them have been shown to be active histone 
demethylases (Fig. 1.4). JMJD6 is the only histone demethylase that removes 
methyl groups from arginine residues on histones (Chang et al. 2007), whereas 
the other histone demethylases remove methyl groups from lysine residues. An 
obvious feature of these enzymes is that they often contain chromatin-binding 
modules, such as the PHD finger (PHD), tudor (Tdr) domain or CXXC zinc-
finger domain (CXXC), which may facilitate targeting the histone demethylases 
to specific genomic regions. Most of these enzymes localize to nuclei consistent 
with a role in regulating chromatin structure.  
 
 
Figure 1.4. Phylogenetic tree of the JmjC family of demethylases 
The names, synonyms, substrates specificities, and domain structures of the JmjC 
family proteins are provided. Figure from Cloos et al. 2007. 
 
JmjC domain-containing proteins have been shown to play a crucial 
role in various physiological processes, including nuclear hormone signaling 
(Yamane et al. 2006; Wissmann et al. 2007), spermatogenesis (Okada et al. 
2007) and cell differentiation (Loh et al. 2007). Consequently, dysregulation of 
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these enzymes has been connected to various human diseases, such as 
neurological disorders and several types of cancer (Shi 2007; Cloos et al. 2008). 
 
1.2.3.  The PHD fingers of chromatin-associated protein recognize 
different state of histone lysine methylation 
 
The PHD finger is a conserved zinc finger domain that is present in a large 
number of chromatin-associated factors and has emerged as a motif that 
recognizes different methylation state of lysine residues on histone H3 tails 
(Adams-Cioaba and Min 2009). The typical PHD finger consists of a Cys4-His-
Cys3 containing segment coordinated to two Zn2+ ions (Fig 1.5, left panel). 
According to their methyl lysine-binding specificity, the PHD fingers can be 
divided into several subclasses. The first subclass of PHD fingers, represented 
by BPTF and ING2, recognizes H3K4me3 (Li et al. 2006; Pena et al. 2006; Shi 
et al. 2006; Wysocka et al. 2006), engages H3K4me3 and H3R2 simultaneously 
in two adjacent channels that are separated by a conserved tryptophan residue 
(Fig. 1.5, middle panel). A second subclass of PHD fingers, including those of 
BHC80 and DNMT3L, specifically interacts with unmodified H3K4 (Ooi et al. 
2007; Lan et al. 2007). Instead of utilizing an aromatic cage/channel, the 
specificity for the association is established through an electrostatic bridge 
between the unmodified epsilon amino group of H3K4 and an acidic residue in 
the PHD finger (Fig. 1.5, right panel). It seems that many other PHD fingers do 
not fit into the two subclasses above, and therefore may be associated with yet 
to be characterized methyl-lysine residues on histones. In support of this, one of 
the two PHD fingers of the histone demethylase SMCX/KDM4C has been 
shown to recognize H3K9me3 (Iwase et al. 2007).  
The PHD fingers are not only present in histone modifying enzymes 
but also in general transcription factors. A recent report has revealed that the 
basal Pol II-specific transcription factor TFIID directly binds to H3K4me3 via 
the PHD finger of TAF3 (Vermeulen et al. 2007). Consistent with 
misinterpretation of histone modifications being detrimental to the cell, 
mutations within the PHD fingers have been associated with a wide variety of 
human diseases. For instance, point mutations, deletions or chromosomal 
translocations of the PHD fingers of RAG2 and ING1 have been associated with 
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immunological disorders, cancers and neurological diseases (Baker et al. 2008). 
Moreover, a recent study has demonstrated that fusing an H3K4me3-binding 
PHD finger to NUP98 is sufficient to induce leukaemia (Wang et al. 2009). 
 
 
Figure 1.5. Readout of histone lysine methylation by the PHD finger 
(Left panel) Topology of the PHD finger fold. Blue arrows, two small β-strands that 
bridge the interleaved zinc-finger motifs; labeled white circles, zinc-coordinated 
cysteine and histidine residue; green cylinder, short α-helix (α1) near the C terminus; 
pink circles, the caging residues for readout of methyl-lysine or unmodified lysine 
mark. (Middle panel) Specific recognition of H3K4me3 by the PHD finger of BPTF. 
The H3 peptide resides in a surface groove between α1 and β1-strand upon formation 
of the antiparallel β-sheet with the core β-strands. Note the full aromatic cage formed at 
the protein surface for trimethyl-specific readout. H3K4 site specificity is achieved by 
simultaneous recognition of H3K4me3 and H3R2, as well as by anchoring of the N 
terminus zinc ions within the zinc-finger motifs. (Right panel) Specific readout of 
unmodified H3K4 peptide by the PHD finger of BHC80. The module has a surface 
patch of acidic residues for unmodified H3K4 mark recognition. Figure from Taverna 
et al. 2007. 
 
1.3.  The structure of rRNA genes and the Pol I transcription 
apparatus 
 
The rate of cell growth and proliferation depends on the cellular capacity of 
protein synthesis, which in turn is linked to ribosome biogenesis. Ribosomal 
RNA (rRNA) is the major catalytic and architectural component of a ribosome, 
and therefore transcription of rRNA genes (rDNA) is a central step of ribosome 
biogenesis. In cycling cells, about 50% of cellular transcription activity is 
expended in the synthesis of rRNA. Thus, it is not surprising that the cell has 
evolved complex regulatory mechanisms to control rRNA synthesis. Practically 
all signaling pathways that affect cell growth also regulate rDNA transcription 
by modulating the activity of Pol I-specific transcription factors. In addition, 
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regulation of rDNA transcription occurs also by modulating the chromatin 
structure of rDNA. 
Mammalian cells contain 200-400 copies of tandemly repeated rRNA 
genes located in specific nuclear compartments, the nucleoli. Clusters of rDNA 
repeats, termed nucleolar organizer regions (NORs), are located on different 
chromosomes, e.g. in humans on the short arms of acrocentric chromosomes 13, 
14, 15, 21 and 22. Each rRNA gene encodes a precursor transcript (45S pre-
rRNA) that is subsequently processed into mature 18S, 5.8S and 28S rRNAs. 
The 43 kb human rDNA transcription units comprise sequences encoding pre-
rRNA (13 kb) that are separated by intergenic spacer (IGS) sequences (30 kb). 
Multiple regulatory elements reside within the IGS, including the rDNA 
promoter, the upstream terminator T0 and the downstream terminators (T1-10) 
(Fig. 1.6). 
 
 
rRNA genes are transcribed by RNA polymerase I (Pol I). In 
mammals, Pol I is found in a complex of >1MDa consisting at least 13 core 
subunits and several Pol I-associated factors (Miller et al. 2001). Interestingly, 
cellular Pol I exists in two functionally distinct complexes (Pol Iα and Pol Iβ). 
Pol Iα, which comprises the majority (>90%) of the total cellular Pol I, is 
unable to initiate transcription at the rDNA promoter but rather catalyzes the 
random synthesis of RNA. Therefore, Pol Iα probably represents the elongating 
Pol I complex. In the other hand, the initiation-competent form Pol Iβ contains 
Pol I-specific transcription factor TIF-IA and is able to direct accurate initiation 
of transcription from the rDNA promoter. 
UBF is a Pol I-specific transcription activator that contains six HMG 
(high mobility group) DNA binding motifs. The HMG boxes enable UBF to 
 
Figure 1.6. The mammalian rDNA transcription unit  
The scheme outlines a representative mammalian rDNA repeat, illustrating the rDNA 
promoter, the upstream terminator (T0), the pre-rRNA coding region, the downstream 
terminators (T1-10), and the intergenic spacer (IGS).  
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bend DNA to form the enhancesome, a nucleosome-like structure thought to be 
required for rDNA transcription (Stefanovsky et al. 2001). In addition, UBF has 
been shown to be involved in the formation of preinitiation complex (Bell et al. 
1988), promoter escape (Panov et al. 2006), transcription elongation 
(Stefanovsky et al. 2006) and the determination of the number of active rRNA 
genes (Sanij et al. 2008).  
 
1.4.  rRNA genes exist in two distinct epigenetic states 
 
Despite rDNA transcription is limiting for cell growth, less than 50% of the 
rRNA genes are transcriptionally active. The proportion of active and silent 
rRNA genes can be identified by their different susceptibility to the DNA cross-
linking agent psoralen (Sogo and Thoma 1989). Transcriptionally active rRNA 
genes are accessible to psoralen and are free of regularly spaced nucleosomes, 
whereas inactive rDNA gene copies are inaccessible to psoralen and display 
regularly spaced nucleosomes (Conconi et al. 1989). The ratio of active and 
inactive rRNA genes is stably propagated through cell cycle, which suggests 
that epigenetic regulation mechanism is involved in modulating the chromatin 
structure of rDNA.  
Distinct chromatin modifications are associated with transcriptionally 
active and silent rDNA repeats (Fig. 1.7). Typical euchromatic marks, such as 
DNA hypomethylation of CpG residues, acetylation of histones and methylation 
at H3K4 are present at active rRNA genes, whereas hypermethylated CpG 
residues, histone hypoacetylation, methylation at H3K9, H3K27 and H4K20 are 
associated with silent rDNA repeats (Santoro et al. 2002; Zhou et al. 2002; 
Santoro and Grummt. 2005). A key factor that establishes heterochromatin at 
the rDNA promoter is an ATP-dependent chromatin remodeling complex, 
termed NoRC (Nucleolar Remodeling Complex). NoRC is composed of the 
regulatory subunit TIP5 and the ATPase SNF2h. TIP5 binds exclusively to 
inactive rDNA repeats and serves as a scaffold to recruit the Sin3a-HDAC 
corepressor complex, the histone H3K9 methyltransferase SETDB1, as well as 
DNA methyltransferases DNMT1 and DNMT3 (Santoro et al. 2002; Zhou et al. 
2002). In addition, NoRC is capable to shift the promoter-bound nucleosome 
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into the silent position, which impairs binding of the Pol I-specific transcription 
factor UBF to the rDNA promoter (Li et al. 2006).  
 
 
Figure 1.7. rDNA repeats exist in two distinct chromatin states 
Active rRNA genes possess a typical euchromatical structure consisting of 
acetylation of histones, methylation of H3K4 and hypomethylated CpG residues. In 
contrast, silent rRNA genes are packaged into heterochromatin containing 
methylation at H3K9, H4K20, hypermethylated CpG residues and are also bound by 
heterochromatin protein HP1.  
 
Compared to NoRC-dependent silencing of rDNA, little is known 
about the molecular mechanism that establishes the epigenetically active state of 
rDNA repeats. A putative candidate for an active chromatin remodeler is CSB 
(Cockayne Syndrome Protein B), a DNA-dependent ATPase that activates 
rDNA transcription in an ATP-dependent manner. CSB is capable to recruit the 
histone methyltransferase G9a to the pre-rRNA coding region, where G9a 
methylates H3K9, a mark that is associated with transcription elongation 
(Bradsher et al. 2002; Yuan et al. 2007). Moreover, other ATP-dependent 
remodelers have also been shown to stimulate rDNA transcription, such 
as WICH, a complex comprising WSTF (Williams Syndrome Transcription 
Factor) and the ATPase SNF2h,  and Mi2β (Percipalle et al. 2006; Shimono et 
al. 2005). However, the molecular mechanism underlying is not well known.  
Regulation of histone lysine methylation is required for proper 
transcription of rRNA genes. Several histone H3K9 methyltransferases, i.e. 
SETDB1, SUV39H1 and G9a have been shown to modulate the chromatin 
structure of rDNA (Santoro et al. 2002; Yuan et al. 2007; Murayama et al. 
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2008). To dynamically regulate H3K9 methylation, one would predict that there 
is a histone demethylase removing H3K9me. Previous studies have shown that 
the histone demethylases KDM3 and KDM4 are capable to demethylate 
H3K9me (Yamane et al. 2006; Cloos et al. 2006; Fodor et al. 2006; Klose et al. 
2006; Whetstine et al. 2006). However, it is not known whether these 
demethylases serve a function at rDNA. The first identified JmjC domain-
containing protein that modifies nucleolar chromatin is KDM2B (also known as 
JHDM1B or FBXL10). KDM2B was shown to repress rDNA transcription by 
demethylating the active histone mark H3K4me3 (Frescas et al. 2007). In other 
studies KDM2B has been shown to demethylate H3K36me2 and to inhibit cell 
proliferation and senescence through silencing of the p15ink4b tumor suppressor 
gene (He et al. 2008; Tzatsos et al. 2009). Moreover, KDM2B has also been 
reported to repress c-Jun expression and to protect cells from H2O2-induced 
apoptosis and G2/M arrest. The biological role of other JmjC family proteins in 
the context of rDNA transcription is yet to be elucidated. 
 
1.5.  The PHF2/PHF8/KIAA1718 subfamily of JmjC domain-
containing proteins 
 
The PHF2/PHF8/KIAA1718 subfamily of JmjC domain-containing proteins 
contains a PHD finger in addition to the JmjC domain (Fig. 1.4). The presence 
of a PHD finger, a module recognizing different methylation state of lysine 
residues on histones, suggests a function of this group of proteins in the 
regulation of chromatin structure and transcription. No enzymatic activity has 
yet been assigned to these proteins and very little is known about their function. 
Proteins of the PHF2/8/KIAA1718 subfamily are evolutionarily conserved from 
yeast to humans. Interestingly, deletion of the C. elegans PHF2/PHF8 ortholog 
4F429 causes embryonic lethality with a low penetrance (Fernandez et al. 
2005), suggesting that this protein plays a role in development. A genome-wide 
screen of MoMuLV-induced T cell lymphomas have revealed provirus 
insertions upstream of PHF2 and PHF8 (Pfau et al. 2008), suggesting that both 
proteins may be involved in the development of lymphomas. The last member 
of this subfamily is KIAA1718, which lies on human chromosome 7q34 
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encoding a 941 aa protein. The biological function of KIAA1718 is unknown. 
Human PHF2 lies on chromosome 9q22 and encodes a 1099 aa 
protein. In mice, PHF2 is ubiquitously expressed, particularly concentrated in 
the embryonic neural tube and root ganglia. The expression pattern and 
chromosomal localization suggest that PHF2 is a candidate gene for hereditary 
sensory neuropathy type 1, HSN1 (Hasenbusch-Theil et al. 1999). Moreover, a 
variety of chromosome aberrations at chr.9q22 have been related to different 
malignancies including breast cancer, and mutations in PHF2 has been 
identified in these patients (Sinha et al. 2008). 
The gene encoding human PHF8 is located on the X-chromosome at 
p11.22. It contains 22 exons encoding a 1024 aa protein. Mutations of PHF8 are 
associated with a disease termed X-linked mental retardation (XLMR) (Siderius 
et al. 1999; Laumonnier et al. 2005; Abidi et al. 2007; Koivisto et al. 2007). 
XLMR is an inherited disease that causes failure to develop cognitive abilities 
because of mutations in numerous genes on the X chromosome. This disease is 
a highly heterogeneous condition affecting around 1.6/1000 males, with a 
carrier frequency of 2.4/1000 females. Over the years, more than 60 XLMR-
associated genes have been identified (Ropers 2006). Mutation in some of these 
genes give rise to clinically distinguishable syndromic forms of mental 
retardation, such as fragile X syndrome and Rett syndrome, whereas others have 
been implicated in non-syndromic XLMR. Intriguingly, many XLMR-related 
genes have a direct role in modulation of chromatin structure, such as MECP2, 
JARID1C, ATRX, PHF6 and PHF8. In particular, JARID1C encodes a JmjC 
domain-containing histone demethylase that specifically targets H3K4me2/3. 
Over twenty mutations in JARID1C have been reported in patients with XLMR 
(Jensen et al. 2005; Tzschach et al. 2006; Abidi et al. 2008). Although most of 
these mutations are not located in the functional PHD finger and JmjC domain, 
they indeed impair chromatin binding and demethylation activity of JARID1C 
(Iwase et al. 2007; Tahiliani et al. 2007). In support of specific histone 
demethylases being involved in XLMR, disease-causing mutations result in 
truncations of PHF8 that apparently compromise its demethylation function. 
PHF8 is ubiquitously expressed in mouse embryos, especially in the embryonic 
and early postnatal stages of brain development. A higher expression is 
observed in the cerebellum (granular layer) and hippocampus of the adult brain 
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(Laumonnier et al. 2005), i.e. are structures that are potentially involved in 
processes underlying memory and learning abilities. 
 
1.6.  Objectives 
 
Active and silent rDNA repeats exhibit two distinct states of chromatin 
structure, euchromatic marks, i.e. acetylation of histone H4 and methylation of 
H3K4 correlate with transcriptional activation, whereas CpG hypermethylation 
and methylation of H3K9 and H4K20 are characteristic of transcriptional 
silencing. The specific pattern of histone methylation is established  and 
maintained by a coordinated interplay of histone methyltransferases and 
demethylases. Several histone H3K9 methyltransferases i.e. G9a, SETDB1 and 
SUV39H1, have been shown to methylate H3K9 at rRNA genes, whereas the 
enzyme that removes methyl groups from H3K9 at rDNA is yet unknown. GFP-
tagging of JmjC domain-containing proteins revealed that two putative histone 
demethylases PHF2 and PHF8, localize in nucleoli, suggesting a function in 
nucleolar chromatin dynamics and epigenetic regulation. To investigate the role 
of PHF2 and PHF8 in rDNA transcription, the following issues should be 
addressed. 
•     Generation of antibodies against PHF2 and PHF8, and expression 
constructs of PHF2 and PHF8.  
•     Examination of the cellular distribution of PHF2 and PHF8 as well as their 
association with rDNA and the Pol I transcription machinery.  
•   Gain-of-function and loss-of-function assays should reveal whether PHF2 
and PHF8 serve a function on rDNA transcription. If so, point mutants in 
the functional important PHD finger and JmjC domain should be generated 
and their effects on rDNA transcription have to be assayed. 
•     Examination of the methyl-lysine binding specificity of the PHD fingers of 
PHF2 and PHF8. 
•     Identification of the specific methylated lysine residues on histones that can 
be demethylated by PHF2 and PHF8.  
•     Study of the functional link of PHF2 and PHF8 with the identified nucleolar 
JmjC domain-containing histone demethylase KDM2B.  
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•     Mutations of human PHF8 are associated with the disease X-linked mental 
retardation (XLMR). Therefore, the PHF8 point mutant (PHF8-F279S) that 
is found in XLMR patients should be generated and its nucleolar function 
has to be examined. 
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2. Materials and Methods 
 
2.1.  Materials 
 
2.1.1.  Antibodies 
 
 
Table 1 Primary antibodies 
 
Name Type Source Application 
 
Anti-PHF2 Rabbit, polyclonal T. Jenuwein’s lab 
 
WB (1:1000) 
Anti-PHF8 Rabbit, polyclonal Home made  
(W. Feng) 
WB (1:2000) 
Anti-HA Mouse, monoclonal Munich 
 
ChIP 
Anti-HA 
(agarose) 
Mouse, monoclonal Sigma-Aldrich 
(Cat. A2095) 
IP 
Anti-Flag (M2) Mouse, monoclonal, 
IgG1 
Sigma-Aldrich 
(Cat. F2426) 
WB (1:3000) 
Anti-Flag (M2) 
(agarose) 
Mouse, monoclonal, 
IgG1 
Sigma-Aldrich 
(Cat. A2220) 
IP 
 
Anti-Flag-Cy3 
 
Mouse, monoclonal, 
IgG1, conjugate 
Sigma-Aldrich 
(Cat. A9594) 
IF 
Anti-V5 Mouse, monoclonal 
 
Invitrogen 
(Cat. 46-0705) 
WB (1:5000) 
Anti-V5 Rabbit, polyclonal Bethyl 
(Cat. A190-220A) 
WB (1:5000),  
IP, ChIP 
Anti-V5 
(agarose) 
Mouse, monoclonal Sigma-Aldrich 
(Cat. A7345) 
IP 
Anti-RPA116 Rabbit, polyclonal  Home made  
(Seither et al.) 
WB (1:1000),  
IP, ChIP 
Anti-UBF Rabbit, polyclonal Home made 
 
ChIP 
Anti-Pol I Human, polyclonal Autoimmune serum 
#S57299 
IP, IF 
Anti-UBF Human, polyclonal Autoimmune serum 
(Zatsepina et al. 1993) 
IP 
Anti-UBF (F-9) Mouse, monoclonal SantaCruz  
(Cat, sc-13125) 
WB (1:500), IF 
Anti-α-Tubulin Mouse, monoclonal Calbiochem  
(Cat. CP06) 
WB (1:1000) 
 
Anti-MLL1 
 
Rabbit, polyclonal Bethyl 
(Cat. A300-086A-1) 
WB (1:500) 
Anti-H3 Rabbit, polyclonal Abcam  
(Cat. ab1791) 
ChIP 
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Anti-H3K4me1 Rabbit, polyclonal Abcam  
(Cat. ab8895) 
ChIP 
Anti-H3K4me2 Rabbit, polyclonal Upstate 
(Cat. 07-030) 
ChIP 
Anti-H3K4me3 Rabbit, polyclonal Abcam  
(Cat. ab8580) 
ChIP 
Anti-H3K9me1 Rabbit, polyclonal T. Jenuwein’s lab 
 
ChIP 
 
Anti-H3K9me2 Rabbit, polyclonal T. Jenuwein’s lab 
 
ChIP 
 
Anti-H3K9me3 Rabbit, polyclonal Upstate  
(Cat. 07-442) 
ChIP 
Anti-H3K27me2 Rabbit, polyclonal T. Jenuwein’s lab 
 
ChIP 
 
Anti-H3K27me3 Rabbit, polyclonal Upstate  
(Cat. 07-449) 
ChIP 
Anti-H3K36me1 Rabbit, polyclonal Abcam  
(Cat. ab1783) 
ChIP 
 
Anti-H3K36me2 Rabbit, polyclonal Upstate  
(Cat. 07-369) 
ChIP 
Anti-H3K36me3 Rabbit, polyclonal Abcam  
(Cat. ab1785) 
ChIP 
Anti-H4K20me3 Rabbit, polyclonal Abcam  
(Cat. ab9053) 
ChIP 
Anti-acetyl-H4 Rabbit, polyclonal Upstate  
(Cat. 06-866) 
ChIP 
 
Table 2 Secondary antibodies and IgGs 
 
 
 
Name Type Source Application 
Goat anti-mouse 
HRP-conjugated 
IgG (H+L) Jackson Immunoresearch 
Laboratories, Inc 
WB (1:5000) 
 
Goat anti-rabbit 
HRP-conjugated 
IgG (H+L) Jackson Immunoresearch 
Laboratories, Inc 
WB (1:5000) 
Mouse IgGs  Dianova IP, ChIP 
Rabbit IgGs  Dianova IP, ChIP 
 
Human IgGs  Dianova IP, ChIP 
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2.1.2.  Primers 
 
Table 3. Primers for qPCR 
 
Name Sequence Applicaton 
 
hrDNA (promoter) 
(-49 / +32) 
Forward: 5'-GGTATATCTTTCGCTCCGAG-3' 
Reverse: 5'-GACGACAGGTCGCCAGAGGA-3' 
ChIP 
hrDNA (promoter) 
(-150 / +32) 
Forward: 5'-CGATGGTGGCGTTTTT-3' 
Reverse: 5'-GACGACAGGTCGCCAGAGGA-3' 
ChIP 
 
HrDNA (18S rRNA) 
(+3990 / +4092) 
Forward: 5'-CGACGACCCATTCGAACGTCT-3' 
Reverse: 5'-CTCTCCGGAATCGAACCCTGA-3' 
ChIP 
 
hrDNA (28S rRNA) 
(+7936 / +8036) 
Forward: 5'-GCGACCTCAGATCAGACGTGG-3' 
Reverse: 5'-CTGTTCACTCGCCGTTACTGAG-3' 
ChIP 
hrDNA (IGS-1) 
(+18155 / +18280) 
Forward: 5'-GTTGACGTACAGGGTGGACTG-3' 
Reverse: 5'-GGAAGTTGTCTTCACGCCTGA-3' 
ChIP 
hrDNA (IGS-2) 
(+27365 / +27475) 
Forward: 5'-CCTTCCACGAGAGTGAGAAGC-3' 
Reverse: 5'-TCGACCTCCCGAAATCGTACA-3' 
ChIP 
hrDNA (Enhancer)  
(-1020 / -927) 
Forward: 5'-AGAGGGGCTGCGTTTTCGGCC-3' 
Reverse: 5'-CGAGACAGATCCGGCTGGCAG-3' 
ChIP 
hrDNA (5’ ETS) 
(+307 / +442) 
Forward: 5'-TGTCAGGCGTTCTCGTCTC-3' 
Reverse: 5'-AGCACGACGTCACCACATC-3' 
RT-PCR 
hPHF2 Forward: 5'-AAGAGTGCAGGCAAACGACT-3' 
Reverse: 5'-TCGACCGGGACTTAAAGATG-3' 
RT-PCR 
hPHF8 Forward: 5'-TGGATGAACAGGACAGCTTG-3' 
Reverse: 5'-GGGTCGAGATTTCAAAGCAG-3' 
RT-PCR 
hKDM2B Forward: 5'-GAGGAGAAGAAGAAGGTGAAG-3' 
Reverse: 5'-TTGATGGGCTGCTGGTTC-3' 
RT-PCR 
hβ−actin Forward: 5'-CGTCACCAACTGGGACGACA-3' 
Reverse: 5'-CTTCTCGCGGTTGGCCTTGG-3' 
RT-PCR 
hGAPDH Forward: 5'-CCCATCACCATCTTCCAGGAG-3' 
Reverse: 5'-CTTCTCCATGGTGGTGAAGACG-3' 
RT-PCR 
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Table 4. Primers for mutagenesis 
 
hPHF8-Y7A Sense:       5’-CTCGGTGCCGGTGGCTTGCCTCTGCCGG-3’ 
Antisense: 5’-CCGGCAGAGGCAAGCCACCGGCACCGAG-3’ 
hPHF8-H247A Sense:       5’-GAGATAGCTATACAGACTTTGCCATTGACTTTG-                           
GTGGCACCT-3’ 
Antisense: 5’-AGGTGCCACCAAAGTCAATGGCAAAGTCTGTA- 
                  TAGCTATCT-3’ 
hPHF8-
H247A, I248A, 
D249A 
Sense:       5’-GTGCGAGATAGCTATACAGACTTTGCCGCTG- 
                 CCTTTGGTGGCACCTCTGTCTGGTA-3’ 
Antisense: 5’-TACCAGACAGAGGTGCCACCAAAGGCAGCGGC-      
AAAGTCTGTATAGCTATCTCGCAC-3’ 
hPHF8-F279S Sense:          5’-AAATGCCAATCTGACTCTCAGTGAGTGCTGG- 
                    AGCAGTTCC-3’ 
Antisense: 5’-GGAACTGCTCCAGCACTCACTGAGAGTCAGAT-
TGGCATTT-3’ 
mPHF8-Y7A Sense:        5’-GCCTCGGTGCCTGTGGCTTGCCTCTGTCGACT-3’ 
Antisense: 5’-AGTCGACAGAGGCAAGCCACAGGCACCGA- 
      GGC-3’ 
mPHF2-Y7A Sense:       5’-GACGGTGCCCGTGGCCTGCGTCTGCCGG-3’ 
Antisense: 5’-CCGGCAGACGCAGGCCACGGGCACCGTC-3’ 
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2.1.3.  siRNA oligos 
 
Table 5 siRNA oligos 
 
Name Target sequence 
 
si-hPHF2 (1943) 5’-GAGGCCAAGTGGAAGTACA-3’ 
si-hPHF2 (1966) 5’-CAGCAAACCTGACTCCTTA-3’ 
si-hPHF8 (2202) 5’-GGAGGACTATACAACAGAT-3’ 
si-hPHF8 
siGENOME SMARTpool,  
Dharmacon, D-004291-01 
5’-GAACCAAGAUAGCAAAGAA-3’ 
5’-CAGCAGACCUCUUCAGAUU-3’ 
5’-GGAGGGAACUUCUUACACA-3’ 
5’-GGACAUCUUUCGCGGUUUG-3’ 
si-hKDM2B 
siGENOME SMARTpool, 
Dharmacon, D-014930-01 
5’-GCAAUAAGGUCACUGAUCA-3’ 
5’-GACCUCAGCUGGACCAAUA-3’ 
5’-GGGAGUCGAUGCUUAUUGA-3’ 
5’-CAGCAUAGACGGCUUCUCU-3’ 
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2.1.4.  Standard buffers and solutions 
 
MOPS (10 x)                     200 mM MOPS  
                                           50 mM NaAc  
                                           10 mM EDTA 
 
Laemmli buffer (2 x)         125 mM Tris-HCl pH 6.8 
                                           4%  SDS 
                                           20%  Glycerol  
                                           10%  2-mercaptoethanol 
                                           0.004% Bromophenol blue 
 
PBS                                    137 mM NaCl 
                                           2.7 mM KCl 
                                           10 mM Na2HPO4,  
                                           2 mM KH2PO4 
 
PBST                                 PBS containing 0.1% Tween 20 
 
Ponceau S                           5% Acetic acid (v/v) 
                                            30% Trichloroacetic acid (TCA) (v/v),  
                                            2% Ponceau S (w/v) 
 
RNA loading buffer             50% Glycerol 
                                             1 mM EDTA 
                                             0.25% Bromophenol blue 
 
SDS running buffer (10 x)   250 mM Tris base 
                                             1% SDS 
                                             1.9 M Glycine      
 
SSC (20 x)                           3 M NaCl 
                                             0.3 M Na-Citrate 
 
TBE buffer                           90 mM Tris-HCl pH 8.3 
                                             2.5 mM EDTA  
                                             90 mM Boric acid 
 
TE buffer                             10 mM Tris-HCl pH 8.0 
                                             1 mM EDTA 
 
WB transfer buffer               25 mM Tris base 
                                             192 mM Glycine 
                                             20 % Methanol  
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2.2.  Methods 
 
2.2.1.  Cloning and constructs 
 
2.2.1.1. Plasmid DNA 
 
A cDNA clone, hj04651s1, encoding the open reading frame (ORF) of human 
PHD finger protein 8 (PHF8) (KIAA1111, GenBank accession number 
AB029034), was obtained from the cDNA Bank Section Kazusa DNA Research 
Institute, Japan. The coding sequence of human PHF8 was PCR-amplified and 
cloned into the Gateway entry vector pDONR/Zeo (Invitrogen). The entry 
vectors pDONR/Zeo-PHF2, encoding murine PHD finger protein 2 (PHF2) 
(GenBank accession number BC051633) and pDONR/Zeo-KDM2B, encoding 
murine lysine demethylase 2B (KDM2B) (GenBank accession number 
NM_001003953.1) were provided by T. Jenuwein, Vienna, Austria. The 
Gateway entry vetor pDONR-WDR5, encoding human WD40-repeat protein 
(WDR5) was obtained from the clone library of the core facility of DKFZ. To 
generate expression vectors, the entry clones were transferred into Gateway 
compatible destination vectors, i.e. pI-GW-GFP, pcDNA4.0-FLAG-HA-GW, 
pEF-GW-V5 (Invitrogen). Point mutants of PHF2 and PHF8 were generated 
with QuickChange site-directed mutagenesis kit (Stratagene) and verified by 
DNA sequencing. pHrP2-BH is an artificial ribosomal minigene containing a 
5’-terminal human rDNA fragment (from -411 to +375) fused to two rDNA 
terminator elements.  
 
2.2.1.2. Transformation of bacteria 
 
Competent E. coli cells, such as DH5α and BL21 CodenPlus (DE3), were 
incubated with plasmid DNA on ice for 30 minutes. After heated at 42oC for 90 
seconds and cooled on ice for 2 minutes, the cells were mixed with 1 ml of LB 
medium and incubated at 37oC for 1 hour with shaking. The transformed cells 
were then plated on LB agar plates containing appropriate antibiotics. 
 
2.2.1.3. Gateway BP reaction 
 
The Gateway entry vector pDONR/Zeo (70 ng), PCR products (20-50 fmol), 
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and 1 µl of 5x BP Clonase II Enzyme mix (Invitrogen) were mixed and 
incubated at room temperature for 1-12 hr. The sample was digested with 
proteinase K (0.2 µg) at 37oC for 10 min before transformation. The 
transformed cells were plated onto low salt LB plates containing zeocin (50 
µg/ml). 
 
2.2.1.4. Gateway LR reaction 
 
The Gateway destination vector (50 ng), entry vector (50 ng) and 1 µl of 5x LR 
Clonase II Enzyme mix (Invitrogen) were mixed and incubated at room 
temperature for 1-12 hr. After digestion with proteinase K (0.2 µg) at 37oC for 
10 min, 1 µl of the reaction was used to transform DH5α competent cells. The 
transformed cells were plated onto LB plates containing ampicillin (50 ng/ml). 
 
2.2.2.  Cell culture and transfection 
 
2.2.2.1.  Cell culture 
 
HEK293 is an epithelial cell line that is derived from primary human embryonic 
kidney transformed by sheared human adenovirus E1A gene product. HEK293T 
is a derivative of the HEK293 cell line into which the temperature sensitive 
SV40 T-antigen was inserted. Due to the expression of SV40 large T-antigen in 
HEK293T cells that allows episomal replication of plasmids containing the 
SV40 origin and early promoter region, HEK293T cells have higher 
transfection efficiency than HEK293 cells. Human osteosarcoma U2OS is a cell 
line derived from a moderately differentiated sarcoma. HEK293T cells and 
U2OS cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM, 
GibcoBRL) supplemented with 10% heat-inactivated (15 min at 65oC) fetal calf 
serum (FCS, GibcoBRL), 1 mM sodium pyruvate (Biochrom AG), 100 U/ml of 
penicillin-streptomycin (Lonza) and 2 mM of glutamine (Lonza).   
 
2.2.2.2. Transient plasmid DNA transfection in HEK293T cells 
 
Transfection of HEK293T cells was performed with calcium phosphate-DNA 
precipitation method. Approximately 20 hours before transfection, cells were 
seeded in 10 ml of DMEM in 10 cm dishes at a density of 1 x 106 cells per 
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plate. Plasmid DNA was diluted in 500 µl of TE/Ca2+ buffer (2 mM Tris-HCl, 
pH 7.4, 0.01 mM EDTA, 0.25 mM CaCl2) and the mix was added drop-wise 
into 500 µl of 2 x HeBS buffer (50 mM HEPES, 280 mM NaCl, 1.5 mM 
Na2HPO4, pH 7.05-7.10). The calcium phosphate-DNA complex was then 
applied to the cells. The original medium was replaced with 10 ml of fresh 
DMEM after 8-10 hours. Cells were harvested 36-48 hours after transfection. 
 
2.2.2.3. siRNA transfection in HEK293T cells 
 
To transfect cells in a 6-well dish, 2.5 µl of Lipofectamine 2000 transfection 
reagent (Invitrogen) was diluted in 250 µl of Opti-MEM I medium (Invitrogen) 
without serum in a sterile tube. In another tube, 60 µmol of siRNA oligos (the 
final concentration of RNA when added to the cells is 40 nM) were added in 
250 µl of Opti-MEM I medium. After incubation at room temperature for 15 
min, the diluted transfection reagent and siRNA oligos were combined and 
incubated at room temperature for 20 min. Meanwhile, the cells were 
trypsinized and plated in 1 ml of DMEM at a density of 4.5 x 105 cells per well. 
After incubation, RNA oligo-Lipofectamin 2000 complexes were applied to the 
cells. Cells were harvested 72- 96 hours after the initial transfection. 
 
2.2.3.  RNA analysis 
 
2.2.3.1. RNA extraction  
 
Cells were washed twice with ice-cold PBS, and lysed in 1 ml of TRIzol reagent 
(Invitrogen). The cell suspension was mixed with 200 µl of chloroform, shaken 
vigorously for 15 seconds, and incubated at room temperature for 5 min. After 
centrifugation (12,000 g, 15 min, 4oC), the aqueous phase was transferred to a 
fresh tube and incubated at room temperature for 10 min after mixing with 400 
µl of isopropanol. RNA was pelleted by centrifugation at 12,000 g, 4oC for 10 
min. The RNA pellet was washed once with 75% ethanol, air-dried and 
dissolved in water by incubating at 55oC for 5-10 min.  
 
2.2.3.2. Northern blot 
 
Three to five microgram of cellular RNA was mixed with freshly prepared 2x 
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RNA denaturing buffer (59% Formamide, 8.7% Formaldehyde, 1.2 x MOPS 
and 58.8 µg/ml Ethidium bromide) and denatured at 65oC for 15 min. Denatured 
RNA was separated on a 1% agarose-MOPS gel and blotted to Hybond N+ 
membrane (Amersham) for at least 16 hours in 10x SSC buffer. The transferred 
RNA was crosslinked to the filter by UV with Stratalinker (Stratagene). The 
filter was pre-hybridized in 10 ml of hybridization buffer containing 0.5 M Na-
phosphate buffer pH 7.2, 10 mM EDTA, 7% SDS for 2-4 hours at 68oC and 
then hybridized with 32P-labelled riboprobes at 68oC for at least 16 hours. After 
washing the filter three times (20 min at 68°C) in 15 ml 0.2 x SSC and 0.1% 
SDS, the blotted RNA was visualized by autoradiography. 
 
2.2.3.3. Preparation of 32P- labeled riboprobes 
 
The DNA templates (200 ng) were mixed with 4 µl of 5 x transcription buffer 
(Promega), 2 µl of 100 mM DTT, 3 µl of 3.3 mM ATP, GTP and CTP mix, 0.3 
µl of 1 mM UTP, 0.5 µl of RNasin (40 U/µl, Promega), 1 µl of T7 polymerase 
(18 U/µl, Promega), and 3 µl of α- [32P] UTP (3000 Ci/mmol, Perkin Elmer). 
The sample was incubated at 37°C for 30 min, and DNA templates were 
digested by incubating with 20 units of RNase free DNase I (Roche) for 15 min 
at 37°C. The reaction was stopped by the addition of 25 µl of stop solution (400 
mM ammonium acetate pH 5.5, 0.4% SDS, 0.2 mg/ml yeast tRNA). To 
precipitate RNA, the sample was mixed with 160 µl of absolute ethanol and 
kept at -20°C for 1 hr. The RNA was pelleted by centrifugation (13,000 rpm, 
room temperature, 15 min), air-dried, and dissolved in 100 µl of sterile water.  
 
2.2.3.4. RT-PCR 
 
Ten microgram of RNA was incubated at room temperature for 15 min with 10 
units of DNase I (Roche) in the presence of 12 units of RNasin (Promega) in 
DNase I digestion buffer containing 40 mM Tris-HCl, pH 7.9, 10 mM NaCl, 6 
mM MgCl2, and 1 mM CaCl2. The reaction was stopped by adding EDTA to the 
final concentration of 8 mM and heating to 75oC for 10 min. DNase I-treated 
RNA (500 ng) was hybridized to 1 µg of random primers dN6 (Roche) by 
incubating at 65oC for 30 min followed by another 30 min incubation at room 
temperature in hybridization buffer (10 mM Tris-HCl, pH 8.5, 150 mM KCl, 1 
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mM EDTA). Reverse transcription reaction was initiated by the addition of 10 
µl of RT buffer (90 mM Tris-HCl, pH 8.5, 8 mM MgCl2, 1.25 mM dNTP, 20 
mM DTT and 12 units of RNasin), and incubated at 42oC for 60 min. The 
cDNA sample was diluted 100 times with destilled H2O before it was used as 
template for qRT-PCR.  
 
2.2.4.  Chromatin fractionation  
 
HEK293T cells were washed with ice-cold PBS, resuspended in buffer A (10 
mM HEPES, pH 7.9, 10 mM KCl, 1.5 mM MgCl2, 0.5 mM DTT, complete 
protease inhibitor cocktail (Roche)) and incubated on ice for 5 min. The cell 
suspension was homogenized in a pre-cooled Dounce tissue homogenizer 
(Wheaton). The nuclei were collected by centrifugation (1,000 g, 5 min, 4oC). 
The supernatant (the cytoplasmic fraction) was mixed with 250 µl of 10 x 
cytoplasmic extraction buffer (300 mM HEPES, pH 7.9, 1.4 M NaCl, 30 mM 
MgCl2), incubated at 4oC for 30 min and clarified by centrifugation (16,000 g, 5 
min, 4oC). The nuclei were washed once in buffer A, lysed for 30 min in 
extraction buffer (20 mM Tris-HCl, pH 8.0, 150 mM NaCl, 1 mM EDTA, 1 
mM EGTA, 0.1% Triton X-100, complete protease inhibitor cocktail). The 
soluble nucleoplasmic fraction was separated from insoluble chromatin by 
centrifugation (2,000 g, 5 min, 4oC). The chromatin was lysed in Laemmli 
buffer, sonicated for 5 min in the Bioruptor (15 sec on, 15 sec off, high level, 
Diagenode) and treated with Benzonase for 15 min at room temperature.  
 
2.2.5.  Cellular extract preparation 
 
HEK293T cells were collected, washed with ice-cold PBS, and resuspended in a 
buffer containing 10 mM Tris-HCl, pH 8.0, 450 mM NaCl, 1 mM EDTA, 1 mM 
EGTA, 1% Triton X-100, complete protease inhibitor cocktail. The suspension 
was sonicated for 5 min in the Bioruptor (15 sec on, 15 sec off, high level), 
incubated at 4oC for 30 min, and clarified by centrifugation (16,000 g, 10 min, 
4oC).  
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2.2.6.  Glycerol gradient centrifugation 
 
A total of 100 µl (380 µg) of nuclear extract from HEK293T cells were layed on 
top of a 3.8 ml of 12.5%-30% glycerol gradient in buffer AM-100 (20 mM Tris-
HCl, pH 8.0, 100 mM NaCl, 5 mM MgCl2, 0.1 mM EDTA, 10% glycerol, 0.5 
mM DTT, complete protease inhibitor cocktail). Samples were ultracentrifuged 
at 4oC for 17 h at 45, 000 rpm in a SW60 rotor. Fractions (each of 200 µl) were 
collected, mixed with 22 µl of trichloroacetic acid (TCA) and incubated at 4oC 
for 45 min. After centrifugation (13,200 rpm/4oC/20min), the pellet was washed 
once with aceton, air-dried and dissolved in 1xLaemmli buffer. 
 
2.2.7.  Immunoblotting 
 
Proteins were denatured for 5 min at 95 oC in Laemmli buffer, separated by 
SDS-PAGE using the Bio-Rad Mini protein gel system and transferred to 
nitrocellulose membrane (Protran, Schleicher & Schuell) using the ‘‘Trans-Blot 
Semi Dry Apparatus’’ (BioRad). The blots were blocked at room temperature 
for 1 hour in blocking solution (0.1% Tween 20 in PBS (PBST), 5% non-fat 
milk) and incubated with primary antibodies at 4 oC overnight. After washing 
three times for 15 min in PBST, the blots were incubated with secondary 
antibodies coupled to horseradish peroxidase (HRP) for 1 hour at room 
temperature followed by washing three times in PBST for 15 min. Proteins were 
detected by using Immobilon Western Chemiluminescent HRP Substrate 
(Millipore) and exposing in LAS-3000 (Fujifilm). 
 
2.2.8.  Coomassie staining  
 
After SDS-PAGE, proteins were fixed in 30% ethanol, 10% acetic acid for at 
least 2 hours at room temperature and stained in 0.01% Coomassie Blue G250 
w/v, 5% ethanol v/v, 8.5% H3PO4 v/v overnight. The gel was destained in 
distilled water for 4 hours and dried at 75oC for 1 hour with a gel dryer 
apparatus (Biorad). 
 
2.2.9.  Immunoprecipitation  
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HEK293T cells were washed with ice-cold PBS, resuspended in buffer A 
containing 0.1% Triton X-100. After incubation on ice for 7 min, nuclei were 
pelleted by centrifugaion (1,500 g/4oC /5min). Nuclei were lysed in IP buffer 
(20 mM Tris-HCl, pH 8.0, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% 
Triton X-100, complete protease inhibitor cocktail) at 4oC for 30 min. The 
lysate was briefly centrifuged and supernatant was kept. The pellet was 
sonicated in IP buffer containg 450 mM NaCl, incubated at 4oC for 20 min and 
diluted with 2 volumn of IP buffer containing no salt. The extract was combined 
with the supernatant from previous step and cleared by centrifugation (16,000 g, 
15 min, 4oC). Nuclear extracts were pre-cleared by incubation with protein A/G 
Sepharose (Amersham) at 4oC for 1 hour. After pre-clearing, the lysates were 
incubated at 4oC overnight with respective antibodies and protein A/G 
Sepharose blocked in IP buffer containing 1 mg/ml BSA for 1 hour at 4oC. 
After successive washing with IP buffer, bound proteins were eluted from beads 
in 1.5 x Laemmli buffer and analyzed on western blots.  
 
2.2.10.  Chromatin immunoprecipitation (ChIP) 
 
Cells were crosslinked with 1% formaldehyde at room temperature for 10 min 
and the reaction was quenched with 125 mM glycine for 5 min. Cells were 
collected, homogenized in PBS containing 1% Triton X-100, and transferred to 
0.5 ml thin wall PCR tubes (Eppendorf). The pellets were resuspended in SDS 
lysis buffer (50 mM Tris-HCl, pH 8.0, 10 mM EDTA, 1% SDS, complete 
protease inhibitor cocktail) and sonicated to yield DNA fragments of 0.2-0.5 kb 
in the Bioruptor (10-20 min, 30 seconds on, 30 seconds off, high level). The 
lysates were diluted at least 10-fold in ChIP dilution buffer (20 mM Tris-HCl, 
pH 8.0, 150 mM NaCl, 2 mM EDTA, 1% Triton X-100, complete protease 
inhibitor cocktail) and pre-cleared with protein A/G Sepharose at 4oC for 1 
hour. After keeping 10% of cleared lysate as the “input” samples, the rest of 
lysates were incubated with the respective primary antibodies overnight at 4oC 
and the immuno-complexes were precipitated with protein A/G Sepharose 
(blocked in ChIP dilution buffer containing 0.5 mg/ml BSA and 0.2 mg/ml 
sonicated salmon sperm DNA) for 2 hours at 4oC. The beads were washed 
sequentially with three-times of high salt washing buffer (20 mM Tris-HCl, pH 
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8.0, 500 mM NaCl, 2 mM EDTA, 1% Triton X-100), three-times of LiCl 
washing buffer (10 mM Tris-HCl, pH 8.0, 250 mM LiCl, 1% Na-deoxycholate, 
1% NP40) and 1 time of TE buffer. Bead-bound DNA was extracted by boiling 
for 10 min in 100 µl of 10% Chelex slurry (Biorad). Proteins were removed 
with digestion with 10 µg of proteinase K at 55oC for 30 min. After boiling for 
10 min to inactivate proteinase K, 60 µl of the supernatant was transferred to a 
fresh tube. The Chelex resin was mixed with 100 µl of destilled H2O, 
centrifuged at 12,000 g for 30 seconds, and 100 µl of the supernatant was 
combined with the previous supernatant. The DNA was analyzed by qPCR in 
the LightCycler 480 apparatus (Roche).  
 
2.2.11.  Methylation-sensitive ChIP-chop 
 
The ChIP DNA samples (15 µl each) were either mock-treated or digested with 
20 units of HpaII (New England Lab) overnight at 37oC. The DNA was 
amplified using primers that amplify human rDNA from -150 to +32 (the 
transcription start site was set as +1), a region covering four HpaII restriction 
sites. For normalization, a DNA fragment harboring rDNA sequence from 
+7936 to +8036 containing no HpaII restriction site was also amplified. 
Quantification of the percentage of HpaII resistance was calculated as follows: 
RHpaII=((XHpaII/Xmock) / (CHpaII/Cmock)) x 100 
X, analyzed fragment and C, control fragment.  
 
2.2.12.  Immunofluorescence 
 
U2OS cells grown on coverslips were rinsed briefly in PBS and fixed with 
either 4% paraformaldehyde (PFA) in PBS for 10 min at room temperature, or 
with methanol for 6 min and aceton for 1 min at -20oC. After washing twice 
with PBS, the PFA-fixed cells were permeabilized with PBS containing 0.2% 
Triton X-100 for 5 min at room temperature. After washing three times with 
PBS, cells were blocked in 5% horse serum (Invitrogen) for 1 hour at room 
temperature and incubated with the primary antibodies overnight at 4oC in a 
humidified chamber. The cells were washed three times with PBS and incubated 
with the secondary antibodies for 1 hour at room temperature in dark. After 
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three times of washing with PBS, the cells were counterstained with 1 µg/ml 
Hoechst for 5 min. The coverslips were rinsed in PBS and mounted onto slides 
with mounting medium. The stained cells were analyzed by fluorescence 
microscopy on a Carl Zeis, Axiophot microscope. 
 
2.2.13.  Expression of GST fusion proteins 
 
E. coli BL21 CodenPlus (DE3) competent cells were transformed with the 
plasmid DNA pGEX6P-mPHF21-120-His6 and pGEX6P-mPHF81-110-His6, and 
single colony from the transformation was picked up and grown in LB medium 
overnight at 37oC. Fifteen ml of overnight bacterial culture was seeded into 800 
ml of LB medium containing 50 µg/ml of ampicillin. After the bacterial cells 
grown at 37oC to an OD600 of 0.6, the expression of specific proteins was 
induced overnight at 18oC with 0.5 mM IPTG. Cells were harvested by 
centrifugation (2,000 g, 20 min, 4oC) and lysed in 20 ml ice-cold STE buffer 
(10 mM Tris-HCl pH8.0, 1 mM EDTA, 150 mM NaCl) containing 2 mg of 
lysozyme. After addition of 200 µl 1 M DTT and 2.8 ml 10% Sarkosyl, the 
sample was sonicated for 2 min (output: 4-4.5 duty: 50%, Branson Sonifier 
250). After removal of cell debris by centrifugation (12,000 rpm, 4oC, 30 min), 
Triton X-100 was added to the supernatant to a final concentration of 2%, and 
the final volume was adjusted to 40 ml with STE buffer. Aliquotes of the lysates 
were frozen in liquid nitrogen and stored at –80oC. 
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3. Results 
3.1. Generation of antibodies against PHF2 and PHF8 
 
PHF2 and PHF8 belong to the family of JmjC domain-containing lysine 
demethylases but so far no cellular function of either protein is known. 
Recently, the closely related lysine demethylase JHDM1B/KDM2B has been 
shown to localize to nucleoli and to repress rDNA transcription via 
demethylating the euchromatic histone mark H3K4me3 (Frescas et al. 2007). To 
study the function of PHF2 and PHF8, polyclonal antibodies against both 
proteins were generated. For this, cDNAs encoding aa 452-750 of human PHF2 
and aa 448-650 of human PHF8 were cloned into the bacterial expression vector 
pGex6P-His6. The fusion proteins GST-PHF2452-750-His6 and GST-PHF8448-650-
His6 (Fig. 3.1A) were expressed in E. coli and purified by affinity 
chromatography using either a glutathione or a Ni2+-NTA resin. The purified 
recombinant proteins were injected into rabbits to produce polyclonal antisera.  
As a first approach to characterize the anti-PHF2 and anti-PHF8 
antisera, Flag-tagged PHF2 (Fl-PHF2) and PHF8 (Fl-PHF8) were expressed in 
HEK293T cells, immunoprecipitated with anti-Flag antibodies and detected on 
western blots. As shown in Fig. 3.1B, anti-Flag antibodies detected about 150 
kDa proteins whose size corresponds to recombinant PHF2 and PHF8. 
Importantly, the antibodies against PHF2 and PHF8 recognized proteins of the 
same size, indicating that both antibodies are specific for the respective protein. 
Moreover, the antibodies were not only capable to detect endogenous PHF2 and 
PHF8 in nuclear extracts from HEK293T cells but also immunoprecipitated 
PHF2 and PHF8 from these extracts (Fig. 3.1C). In contrast, the respective pre-
immune sera neither detect endogenous PHF2 and PHF8 in nuclear extracts nor 
immunoprecipitated them from these extracts, indicating that the generated 
antibodies faithful detect cellular PHF2 and PHF8. 
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Figure 3.1. Anti-PHF2 and anti-PHF8 antibodies specifically recognize      
PHF2 and PHF8 
(A) Schemes of human PHF2 and PHF8 show the PHD finger and the JmjC domain. 
The fragments used as antigens for immunization are indicated.  
(B) Antisera against PHF2 and PHF8 recognize PHF2 and PHF8, respectively. Nuclear 
extracts from HEK293T cells overexpressing Flag-tagged PHF2 (Fl-PHF2) or PHF8 
(Fl-PHF8) were precipitated with anti-Flag antibodies, and bound proteins were 
analyzed on western blots with anti-Flag antibodies and antisera against PHF2 and 
PHF8. Two percent of input and 30% of immunoprecipitated samples were analyzed. 
The molecular weight marker is indicated on the right. 
(C) Anti-PHF2 and anti-PHF8 antibodies immunoprecipitate endogenous PHF2 and 
PHF8. Nuclear extracts from HEK293T cells were subjected to immunoprecipitation 
with anti-PHF2 and anti-PHF8 antibodies or pre-immune sera (Pre). One percent of 
input and 30% of immunoprecipitated samples were assayed by immunoblotting. The 
molecular weight marker is indicated on the right. 
 
3.2. PHF2 and PHF8 localize to nucleoli 
 
Given that the cellular localization of a protein will give a hint of its biological 
function, the distribution of GFP-tagged PHF2 (GFP-PHF2) and PHF8 (GFP-
PHF8) in U2OS cells was examined by fluorescence microscopy. As shown in 
Fig. 3.2A, a bright green staining at nucleolar sites was observed in cells 
expressing GFP-PHF2 and GFP-PHF8. Nucleolar localization was confirmed 
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by co-immunostaining of UBF, a Pol I specific transcription factor and 
nucleolar marker protein. The overlapping staining of UBF with GFP-PHF2 and 
GFP-PHF8 demonstrated that both proteins are enriched in nucleoli. To monitor 
the localization of endogenous PHF2 and PHF8, U2OS cells were 
immunostained with antibodies against PHF2 and PHF8. Consistent with the 
localization of the GFP-PHF2 and GFP-PHF8, the endogenous proteins mainly 
localized within nucleoli and co-stained with UBF (Fig. 3.2B). The nucleolar 
localization of PHF2 and PHF8 suggests that these putative lysine demethylases 
may play a role in rDNA transcription. 
 
 
Figure 3.2. PHF2 and PHF8 localize to nucleoli 
(A) GFP-tagged PHF2 and PHF8 colocalize with UBF in nucleoli. 
U2OS cells overexpressing GFP-tagged PHF2 (G-PHF2) or PHF8 (G-
PHF8) were immunostained with anti-UBF antibodies. Images of phase 
contrast and DNA staining with Hoechst are shown in the first two 
panels.  
(B) Endogenous PHF2 and PHF8 colocalize with UBF in nucleoli. The 
indirect immunofluorescence assays show the localization of 
endogenous PHF2, PHF8, and UBF in U2OS cells. Images of phase 
contrast and DNA staining are shown in the first two panels. 
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3.3. PHF2 and PHF8 are associated with rDNA 
 
3.3.1. PHF2 and PHF8 bind to the entire rDNA repeat 
 
The nucleolar localization of PHF2 and PHF8 raises the possibility that they are 
associated with rDNA. To test this, chromatin immunoprecipitation (ChIP) 
assays were performed. This technique allows the in vivo analysis of 
protein/DNA interactions in intact cells by formaldehyde-fixation of 
nucleoprotein complexes. After disruption of the cells, antibodies are used to 
isolate specific nucleoprotein complexes containing the immunoprecipitated 
proteins and the co-precipitated DNA. The DNA can be isolated and analyzed 
by PCR after reversal of the crosslink. To map the association of PHF8 with 
rDNA, cross-linked chromatin from HEK293T cells was incubated with anti-
PHF8 antibodies or the pre-immune serum. The co-precipitated rDNA was 
analyzed by qPCR using primer pairs encompassing different regions of the 
rDNA repeat, including the enhancer region, the rDNA promoter, the 28S rRNA 
coding region and the intergenic spacer (IGS) which separates individual rDNA 
repeats (Fig. 3.3A). In all tested regions, significant amount of rDNA was co-
precipitated with PHF8, but not with the pre-immune serum (Fig. 3.3B), 
demonstrating that PHF8 was associated with rDNA. In contrast, no significant 
binding of PHF2 to rDNA was detected with anti-PHF2 antibodies (data not 
shown), indicating that either PHF2 does not bind to rDNA or that the part of 
PHF2, which was used to generate the anti-PHF2 antiserum, is inaccessible due 
to cross-linking. To distinguish between both possibilities, binding of 
overexpressed HA-tagged PHF2 (HA-PHF2) to rDNA was examined by ChIP 
assays using anti-HA antibodies for immunoprecipitation. As depicted in Fig. 
3.3B, HA-PHF2 was significantly enriched at rDNA whereas no rDNA bound 
to anti-HA antibodies in mock-transfected cells. Similar to PHF8, HA-PHF2 
was equally enriched at all rDNA regions tested, suggesting that PHF2 and 
PHF8 are associated with the entire rDNA repeat, including the non-transcribed 
intergenic spacer.  
 
 
 
 
                                                                                                                             Results  
        46                                                                                                                                              
  
Figure 3.3. PHF2 and PHF8 are associated with rDNA 
(A) The scheme outlines a representative mammalian rDNA repeat, illustrating the positions of the 
upstream terminator T0, the rDNA promoter, the pre-rRNA coding region, the downstream 
terminators (T1-10), and the intergenic spacer (IGS). Primer pairs used for qPCR in ChIP assays are 
indicated below. 
(B) PHF2 and PHF8 are associated with rDNA. Cross-linked chromatin from HEK293T cells 
overexpressing HA-tagged PHF2 (HA-PHF2, light grey bars) or mock-transfected cells (white 
bars) was precipitated with anti-HA antibodies. Chromatin from HEK293T cells was incubated 
with antibodies against PHF8 (black bars) or the pre-immune sera (dark grey bars). The 
precipitated DNA was analyzed by qPCR using primers indicated in the scheme above. The 
enrichment of HA-PHF2  (scale on the left y-axis) and endogenous PHF8 (scale on the right y-
axis) is reflected as the percentage of input DNA.  
(C) PHF2 and PHF8 bind to active rDNA copies. The scheme on the left shows the principle of 
DNA methylation assay by HpaII digestion. Four HpaII restriction sites (5’-CCGG-3’) are 
presented at the human rDNA promoter, which are unmethylated (represented as white balls) in 
active rRNA genes but methylated (represented as black balls) in silent genes. The qPCR primer 
pair flanking the HpaII sites is indicated with arrows. ChIP input DNA and DNA precipitated by 
indicated antibodies were either digested with HpaII or mock-digested before PCR amplification. 
The relative level of HpaII-resistant, inactive rDNA copies (white bars) and unmethylated, active 
copies (grey bars) was determined by qPCR.  
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3.3.2. PHF2 and PHF8 bind to active rRNA genes 
 
In mammalian cells, rRNA genes consist of transcriptionally active and silent 
copies, which are distinguishable by their DNA methylation status. Whereas 
transcribed rDNA is unmethylated, silent rDNA harbors methylated cytosine 
residues at CpG sites. If this CpG methylation occurs at CCGG, the 
methylation-sensitive restriction enzyme HpaII will not cleave the DNA. 
Therefore, the resistance of genomic DNA to digestion with HpaII is indicative 
for CpG methylation and can be detected in PCR with primer pairs flanking one 
or more HpaII restriction sites. If a PCR-product can be amplified from the 
DNA upon incubation with HpaII, the DNA was methylated and thus resistant 
to digestion by HpaII. In contrast, if the PCR yields no product, the DNA was 
not methylated and thus cleaved by HpaII (Fig. 3.3C, left panel). 
Using this technique, the association of PHF2 and PHF8 with active or 
silent rRNA genes was monitored by digestion of rDNA that was co-
precipitated with PHF8 and HA-PHF2 in ChIP assays with HpaII followed by a 
subsequent PCR amplification of the rDNA promoter using primers that flanks 
the four HpaII restriction sites present at this region. To determine the overall 
ratio of active and silent rRNA genes in HEK293T cells, DNA isolated from 
soluble chromatin (ChIP input) was subjected to HpaII digestion. About 55% of 
rDNA were digested by HpaII, showing that these rRNA genes were 
unmethylated, whereas the rest 45% HpaII-resistant copies were methylated 
(Fig. 3.3C). As control, the CpG methylation status of rDNA associated with 
Pol I or H4K20me3, a transcriptional repressive histone mark, was monitored. 
As shown in Fig. 3.3C, more than 95% of rDNA associated with Pol I were 
digested by HpaII, demonstrating that Pol I binds and transcribes exclusively 
unmethylated rDNA. In contrast, only 5% of rDNA bound to H4K20me3 were 
cleaved by HpaII, showing that H4K20me3 is present predominantly at 
methylated rRNA genes. Notably, 70-80% of PHF2 and PHF8 were associated 
with unmethylated i.e. transcriptionally active rDNA copies. These results 
suggested that PHF2 and PHF8 might serve a positive role in rDNA 
transcription. 
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3.4. PHF2 and PHF8 interact with Pol I and UBF 
 
The observation that PHF2 and PHF8 are preferentially associated with active 
rRNA genes suggests that they may cooperate with the Pol I transcription 
machineray to activate rDNA transcription. To examine whether PHF2 and 
PHF8 are associated with the Pol I transciption apparatus, co-
immunoprecipitation assays were performed. For this, nuclear extracts from 
HEK293T cells overexpressing V5-tagged PHF2 (V5-PHF2) and PHF8 (V5-
PHF8) were incubated with human autoimmune sera against Pol I and UBF 
(Zatsepina et al. 1993), and co-immunoprecipitation of V5-PHF2 and V5-PHF8 
with Pol I and UBF was monitored on western blots. As shown in Fig. 3.4A, 
V5-PHF2 and V5-PHF8 were co-precipitated with antibodies against Pol I and 
UBF, but not with the control human IgGs. To confirm the association of PHF2 
and PHF8 with Pol I and UBF, Fl-PHF2 and Fl-PHF8 were overexpressed in 
HEK293T cells and immunoprecipitated with anti-Flag antibodies. 
Consistently, Pol I and UBF were co-precipitated with Fl-PHF2 and Fl-PHF8, 
whereas in mock-transfected cells no binding of Pol I and UBF to the anti-Flag 
antibodies was observed (Fig. 3.4B). Thus, PHF2 and PHF8 are associated with 
Pol I and UBF in vivo, supporting the notion that these two putative lysine 
demethylases are involved in rDNA transcription. In addition, the interaction of 
PHF2 and PHF8 with Pol I and UBF may be required for their association with 
rDNA. 
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Figure 3.4. PHF2 and PHF8 interact with Pol I and UBF 
(A) Overexpressed PHF2 and PHF8 co-precipitated with Pol I and UBF. Nuclear 
extracts from HEK293T cells overexpressing V5-tagged PHF2 (V5-PHF2) or PHF8 
(V5-PHF8) were precipitated with antibodies against Pol I or UBF. As a control, 
equivalent amount of nuclear extracts from HEK293T cells overexpressing V5-PHF2 
or V5-PHF8 were mixed and incubated with the control human IgGs. One percent of 
input and 30% of precipitated proteins were analyzed by immunoblotting with anti-
V5, anti-RPA116 (the second largest subunit of Pol I complex) and anti-UBF 
antibodies. 
(B) Pol I and UBF co-precipitate with Fl-PHF2 and Fl-PHF8. Nuclear extracts from 
HEK293T cells overexpressing Fl-PHF2 or Fl-PHF8 were precipitated with anti-Flag 
antibodies. One percent of input and 30% of precipitated proteins were assayed on 
western blots with the indicated antibodies. 
 
3.5. PHF2 and PHF8 are required for Pol I transcription 
 
3.5.1. Overexpression of PHF2 and PHF8 stimulates Pol I transcription 
 
The observation that PHF2 and PHF8 interact with active rDNA repeats and the 
Pol I transcription machinery suggests that these enzymes might directly 
regulate rDNA transcription. To test this, HEK293T cells were either mock-
transfected or transfected with expression plasmids encoding Fl-PHF2 and Fl-
PHF8. Two days after transfection, RNA was isolated and the levels of pre-
rRNA were quantified by qRT-PCR with a primer pair flanking the first 
processing site (+414/+419) of human pre-rRNA. Normalization of pre-rRNA 
abundance to β-actin mRNA levels revealed that pre-rRNA synthesis was 
stimulated by 30-50% upon overexpression of PHF2 and PHF8 (Fig. 3.5A, 
upper panel). Considering that also untransfected cells contribute to the average 
level of pre-rRNA, the actual change of pre-rRNA synthesis due to 
overexpression of PHF2 and PHF8 might be underestimated. To circumvent this 
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problem, reporter gene assays were performed. In the experiment shown in Fig. 
3.5A (middle panel), cells were co-transfected with a Pol I-specific reporter 
construct and expression plasmids encoding Fl-PHF2 and Fl-PHF8. The 
reporter construct used was pHrP2-BH, a plasmid that contains an artificial 
rRNA minigene consisting of the human rDNA promoter followed by a short 
sequence of the pUC9 vector and two rDNA terminator elements. Transcripts 
from the reporter plasmid can be specifically detected by qRT-PCR. Notably, as 
compared to cells transfected with the reporter alone, reporter transcripts 
synthesis in cells expressing Fl-PHF2 was enhanced about 2.2 fold, whereas 
overexpression of Fl-PHF8 stimulated reporter transcripts synthesis by about 
70%. This strong stimulation of reporter transcription confirms the observed 
enhancement of pre-rRNA synthesis and suggests that PHF2 and PHF8 are 
limiting factors for rDNA transcription. Thus, the gain-of-function assays 
suggests that PHF2 and PHF8 act as activators of rDNA transcription.  
 
3.5.2. Depletion of PHF2 and PHF8 impairs pre-rRNA synthesis 
 
If PHF2 and PHF8 activate Pol I transcription, then depletion of PHF2 and 
PHF8 should impair pre-rRNA synthesis. To test this, HEK293T cells were 
transfected with either small interfering RNA (siRNA) that specifically target 
PHF2 and PHF8 or with non-target control siRNA. Four days after transfection, 
the levels of cellular PHF2 and PHF8 were monitored on western blots. As 
shown in Fig. 3.5B (upper panel), PHF2 and PHF8 were significantly depleted 
in cells transfected with specific siRNA as compared to cells transfected with 
control siRNA. Notably, the level of PHF8 was not affected by depletion of 
PHF2 and the knockdown of PHF8 did not alter the level of PHF2, 
demonstrating the specificity of the individual siRNA. Pre-rRNA synthesis in 
these cells was measured on northern blots, using a 32P-labeled RNA probe 
complementary to the first 183 nucleotides of unprocessed human pre-rRNA. 
After normalization with the levels of β-actin mRNA, relative pre-rRNA levels 
were compared, revealing a reduction of about 30-40% in cells depleted of 
PHF2 and PHF8 as compared to cells transfected with control siRNA. 
Therefore, PHF2 and PHF8 are required for rDNA transcription, and the level 
of pre-rRNA synthesis directly correlates with the amount of both enzymes. 
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Figure 3.5.  PHF2 and PHF8 activate Pol I transcription 
(A) Overexpression of PHF2 and PHF8 stimulates rDNA 
transcription. HEK293T cells were transfected with expression 
vectors encoding Fl-PHF2 and Fl-PHF8 (upper panel), or 
together with the Pol I specific reporter construct pHrP2-BH 
(middle panel). The amounts of pre-rRNA and reporter 
transcripts were monitored by qRT-PCR and normalized to the 
level of β-actin mRNA. The western blot image in the bottom 
panel shows the expression level of Fl-PHF2 and Fl-PHF8. Error 
bars represent standard deviation of three independent 
experiments. 
(B) Depletion of PHF2 or PHF8 reduces rDNA transcription. 
HEK293T cells were transfected with either siRNA oligos 
targeting PHF2 and PHF8 or control siRNA. The levels of pre-
rRNA and β-actin mRNA were analyzed on northern blots 
(middle panel). The pre-rRNA levels were normalized to β-actin 
mRNA levels and represented in the bar diagram in the bottom 
panel. The cellular levels of PHF2, PHF8 and tubulin upon 
siRNA transfection are shown on western blots in the upper 
panel.  
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3.6. PHF2- and PHF8-dependent activation of rDNA 
transcription requires the PHD finger and JmjC domain 
3.6.1. Generation of PHF2 and PHF8 mutants 
 
PHF2 and PHF8 contain both a PHD finger and JmjC domain. Both domains 
are present in a variety of transcriptional regulators that affect gene expression 
by modulating the chromatin structure. The PHD finger has recently been 
shown to recognize the methylation status of lysine residues, such as H3K4me3 
(Shi et al. 2006; Wysocka et al. 2006). The JmjC domain is capable to catalyze 
demethylation of mono-, di- and tri-methyl lysine residues via hydroxylation in 
an Fe(II)- and αKG-dependent manner (Tsukada et al. 2006). This raises the 
question whether the functions of these domains, i.e. binding to and removing 
methyl group from lysine residues, are required for PHF2 and PHF8-mediated 
activation of rDNA transcription. For this, the function of several PHF2 and 
PHF8 derivatives carrying mutations in these domains was investigated. To 
identify amino acids that are involved in binding to methylated lysine residues, 
the PHD fingers of PHF2 and PHF8 were aligned with ING2 and BPTF, 
proteins harboring PHD fingers that interact with H3K4me3 (Shi et al. 2006; 
Wysocka et al. 2006). This sequence alignment revealed conservation of 
defined residues involved in H3K4me3 binding (Fig. 3.6A), indicating that the 
PHD fingers of PHF2 and PHF8 might interact with H3K4me3 as well. Based 
on this alignment, a mutant was generated by site-directed mutagenesis in which 
tyrosine at position 7 was converted to alanine in the PHD finger and the 
respective mutants (PHF2-Y7A and PHF8-Y7A) were used in the designed 
experiments. Similar approach was used to generate mutants in that essential 
amino acids within the JmjC domain were replaced. A conserved iron-binding 
motif HXD/EXnH in the JmjC domain is present in all active JmjC domain-
containing lysine demethylases (Fig. 3.6B). Mutations within this domain 
abolish the enzymatic activity. To generate a catalytically inactive mutant, the 
first iron-binding residue, histidine 249, was converted to alanine yielding 
mutant PHF2-H249A. For PHF8, three consecutive amino acids including the 
first two iron-binding residues (H247 and D249) and the residue I248 were 
replaced by alanine, yielding mutant PHF8-HID. 
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Figure 3.6. Mutations in the PHD finger and JmjC domains of PHF2 and PHF8 do not 
impair their nucleolar localization and interaction with Pol I and UBF  
(A) Alignment of the PHD fingers of human PHF2 (5-56), human PHF8 (5-56), human ING2 (212-
262) and human BPTF (2867-2918). Residues required for H3K4me3 binding are highlighted and the 
mutant used in this study is indicated by a triangle. 
(B) Alignment of a portion of the JmjC domains of human PHF2 (aa 245-304), human PHF8 (aa 243-
302), human KDM2A (aa 208-267) and human KDM2B (aa 238-297). The predicted first and second 
Fe(II)-binding residues are highlighted and the mutant used in this study is indicated by triangles.  
(C) Immunofluorescence assays show that GFP-tagged wildtype and mutant PHF2 and PHF8 localize 
to nucleoli. U2OS cells overexpressing GFP-tagged wildtype and mutant PHF2 and PHF8 were 
immunostained with anti-UBF antibodies. Images of phase contrast and DNA staining with Hoechst 
are shown in the first two panels.  
(D) Mutant PHF2 and PHF8 interact with Pol I and UBF. Nuclear extracts from HEK293T cells 
overexpressing wildtype and mutant Fl-PHF2 or Fl-PHF8 were incubated with anti-Flag antibodies. 
Two percent of input and 30% of precipitated proteins were analyzed by immunoblotting using 
indicated antibodies. 
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3.6.2. Mutant PHF2 and PHF8 localize to nucleoli and interact with Pol I 
and UBF 
 
To analyze the role of the PHD finger and JmjC domain of PHF2 and PHF8 in 
their cellular localization, the subcellular distribution of the PHF2 (PHF2-Y7A 
and PHF2-H249A) and the PHF8 (PHF8-Y7A and PHF8-HID) mutants was 
monitored. For this, GFP-tagged wildtype and mutant PHF2 and PHF8 were 
expressed in U2OS cells and their localization was detected by fluorescence 
microscopy. As shown in Fig. 3.6C, similar to wildtype GFP-PHF2 and GFP-
PHF8, mutant PHF2 (PHF2-Y7A and PHF2-H249A) and PHF8 (PHF8-Y7A 
and PHF8-HID) localized to nucleoli and co-stained with UBF. Thus, the 
nucleolar localization of PHF2 and PHF8 does not depend on a functional PHD 
finger and JmjC domain.  
It has been shown above that PHF2 and PHF8 interact with Pol I and 
UBF (Fig. 3.4), suggesting that this interaction may be important for their 
function in rDNA transcription. Therefore, it was tested whether the association 
of PHF2 and PHF8 with the Pol I transcription machinery is compromised by 
introducing mutations in the PHD finger and JmjC domain. For this, nuclear 
extracts from HEK293T cells expressing Flag-tagged wildtype and mutant 
PHF2 and PHF8 were incubated with anti-Flag antibodies, and co-precipitation 
of Pol I and UBF was monitored by immunoblotting. As shown in Fig. 3.6D, 
similar amounts of Pol I and UBF were co-precipitated with wildtype and 
mutant Fl-PHF2 and Fl-PHF8, indicating that none of these mutations affected 
the interaction of PHF2 and PHF8 with the Pol I transcription machinery.  
 
3.6.3. The PHD finger and JmjC domain are required for PHF2- and 
PHF8-dependent activation of rDNA transcription 
 
Having shown that mutant PHF2 and PHF8 localize to nucleoli and interact 
with the Pol I transcription machinery, it was next assayed whether these 
mutants, like the wildtype proteins, are capable to activate rDNA transcription. 
For this, wildtype and mutant PHF2 and PHF8 were overexpressed in 
HEK293T cells and pre-rRNA synthesis was monitored by qRT-PCR. As 
detected by western blots, Flag-tagged mutant PHF2 and PHF8 were expressed 
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at similar levels as the wildtype proteins. Pre-rRNA synthesis was enhanced 
about 40% upon overexpression of wildtype Fl-PHF2, whereas neither the PHD 
finger mutant Fl-PHF2-Y7A nor the JmjC domain mutant Fl-PHF2-H249A was 
capable to stimulate Pol I transcription (Fig. 3.7A, upper panel). Likewise, 
overexpression of wildtype Fl-PHF8, but neither Fl-PHF8-Y7A nor Fl-PHF8-
HID, augmented pre-rRNA synthesis (Fig. 3.7B, upper panel). Thus, mutations 
within the PHD finger as well as the JmjC domain abolished the transcription 
activation mediated by PHF2 and PHF8, underscoring the importance of these 
protein modules for the function of both proteins. To confirm this, reporter gene 
assays were performed. The Pol I specific reporter pHrP2-BH was co-
transfected with wildtype and mutant Fl-PHF2 and Fl-PHF8 in HEK293T cells, 
and the synthesis of report transcripts was monitored by qRT-PCR. Consistent 
with PHF2 and PHF8 activating Pol I transcription, the levels of reporter 
transcripts were significantly enhanced upon overexpression of the wildtype Fl-
PHF2 and Fl-PHF8. In contrast, mutations within the PHD finger and JmjC 
domain of PHF2 and PHF8 abolished their capability to activate transcription 
from the Pol I –specific reporter (Fig. 3.7A and Fig. 3.7B, middle panel). Taken 
together, these results reveal that the PHD finger and JmjC domain are 
indispensable for PHF2- and PHF8-dependent activation of rDNA transcription, 
although the nucleolar localization and the association with Pol I machinery are 
not affected by the compromised function of both domains. 
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Figure 3.7. The PHD finger and JmjC domain are 
required for PHF2- and PHF8-dependent 
activation of Pol I transcription 
(A) PHF2-dependent activation of Pol I transcription 
requires the PHD finger and JmjC domain. HEK293T cells 
were transfected with expression vectors encoding Flag-
tagged wildtype and mutant PHF2 (upper panel), or 
together with the Pol I specific reporter construct pHrP2-
BH (middle panel). The synthesis of pre-rRNA and 
reporter transcripts was monitored by qRT-PCR and 
normalized to β-actin mRNA levels. The western blot 
image in the bottom panel shows the expression levels of 
wildtype and mutant Fl-PHF2. Error bars represent 
standard deviation from three independent experiments. 
(B) The PHD finger and JmjC domain are required for 
PHF8-mediated activation of rDNA transcription. 
HEK293T cells were transfected with expression vectors 
encoding Flag-tagged wildtype and mutant PHF8 (upper 
panel), or together with the reporter construct pHrP2-BH 
(middle panel). The synthesis of pre-rRNA and reporter 
transcripts was monitored by qRT-PCR. The western blot 
image in the bottom panel shows the expression levels of 
wildtype and mutant Fl-PHF8. The data are from three 
independent experiments. 
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3.7. PHF2 and PHF8 are associated with chromatin 
 
The observation that mutations in the PHD finger and JmjC domain render 
PHF2 and PHF8 unable to activate pre-rRNA synthesis, suggests that both 
proteins may bind to H3K4me3 and act as lysine demethylases. To regulate Pol 
I transcription, both enzymes should not only interact with the Pol I 
transcription machinery, but also with chromatin. To test this, the association of 
PHF2 and PHF8 with chromatin was examined by biochemical fractionation 
under native condition. HEK293T cells were lysed in hypotonic buffer to 
separate nuclei from the cytoplasm. The nuclei were subsequently disrupted in 
low salt buffer to yield a soluble nucleoplasmic fraction and an insoluble 
chromatin fraction. Chromatin-bound proteins were extracted under high salt 
conditions and by nuclease treatment. The distribution of PHF2 and PHF8 in 
these subcellular fractions was monitored on western blots (Fig. 3.8A). As a 
control, a typical protein for each fraction was monitored in parallel. Tubulin, a 
cytosolic protein, was recovered mainly in the cytoplasmic fraction. TIF-IA, a 
Pol I specific transcription factor, was found mainly in the nucleoplasmic 
fraction but also in the cytoplasmic fraction, probably due to leakage during 
isolation of the nuclei. TIP5, a subunit of the chromatin remodeling complex 
NoRC, was exclusively detected in the chromatin fraction. The expected 
distribution of these marker proteins demonstrated that cellular fractionation 
was properly performed. Notably, PHF2 was mainly found in the chromatin 
fraction, whereas similar levels of PHF8 were detected in both the 
nucleoplasmic and chromatin fraction. Thus, PHF2 appears to be tightly 
associated with chromatin, whereas PHF8 is less strongly bound.  
At the onset of mitosis, chromatin condenses to form chromosomes. 
The Pol I transcription is repressed and nucleoli disintegrate. Many rDNA-
associated proteins, like Pol I, are replaced from chromatin during mitosis. 
However, some factors, like UBF, remain associated with rDNA during mitosis 
at nucleolar organization regions (NORs). To examine whether PHF2 and PHF8 
remain associated with chromatin during mitosis, the distribution of GFP-PHF2 
and HA-PHF8 in mitotic U2OS cells was examined by fluorescence 
microscopy. Notably, the GFP-PHF2 staining pattern matched the DNA 
staining with Hoechst (Fig. 3.8B), showing that GFP-PHF2 remained associated 
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with condensed chromatin in mitotic cell. In contrast, HA-PHF8 was mainly 
excluded from chromatin, demonstrating that HA-PHF8 was not or only weakly 
associated with chromatin during mitosis. This finding is consistent to the 
results from fractionation experiments showing that PHF2 binds more strongly 
to chromatin than PHF8. To examine whether PHF2 binds to NORs during 
mitosis, U2OS cells were co-immunostained with anti-UBF antibodies. As 
shown in Fig. 3.8B, UBF was detected as bright dots within the condensed 
chromosomes depicting the localization of NORs, whereas GFP-PHF2 did not 
match the staining of UBF but rather showed a diffuse staining along the 
chromosomes. Therefore, these results revealed that PHF2 is associated with 
chromatin but is not enriched in NORs during mitosis.  
 
 
Figure 3.8. PHF2 and PHF8 are associated with chromatin 
(A) PHF2 and PHF8 bind to chromatin. HEK293T cells were fractionated into 
cytoplasmic (CF), nucleoplasmic (NF) and chromatin fractions (ChF). Lysates of 
equivalent amounts of cells from each subcellular fraction were analyzed by 
immunoblotting using indicated antibodies. 
(B) PHF2 stays associated with chromatin during mitosis. U2OS cells overexpressing 
GFP-PHF2 or HA-PHF8 were immunostained with antibodies against UBF, Pol I and 
HA epitope. Images of phase contrast and DNA staining with Hoechst are shown in the 
first two panels.  
 
3.8. PHF2 binds to H3K4me3 via the PHD finger 
 
PHD fingers have been shown to interact with methylated lysine residues on 
histone H3. The presence of PHD fingers in PHF2 and PHF8 indicates that 
these enzymes might directly interact with hitone H3. To test this, co-
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immunoprecipitation assays were performed. Nuclear extracts from HEK293T 
cells expressing Fl-PHF2 and Fl-PHF8 were immunoprecipitated with anti-Flag 
antibodies, and co-precipitation of histone H3 was monitored by 
immunoblotting. As shown in Fig. 3.9A, significant amount of H3 was co-
precipitated with Fl-PHF2, whereas only a minor fraction of histone H3 was co-
precipitated with Fl-PHF8. Thus, PHF2 and to a lesser extent also PHF8, 
interact with histone H3 in vivo. The finding that PHF2 exhibited a stronger 
affinity to histone H3 than PHF8 is consistent with the observation that PHF2 
binds more tightly to chromatin than PHF8. To analyze if Fl-PHF2 is also 
associated with histones other than H3, the Fl-PHF2 co-precipitated histones 
were also visualized by Coomassie blue staining. Besides histone H3, other core 
histones, i.e. H2A, H2B and H4 also co-precipitated with Fl-PHF2 in 
stoichiometric amounts, but not histone H1 (Fig. 3.9B), demonstrating that 
PHF2 interacts with nucleosomal core particles but not the linker histone.  
To test if the association of PHF2 with histone H3 is mediated via 
methylated lysine residues, histone H3 that co-precipitated with Fl-PHF2 was 
examined on western blots using antibodies against different histone 
methylations. The relative enrichment of histone methylation marks in Fl-
PHF2-associated histone H3 was calculated relative to the abundance of this 
mark in the nuclear extract. Importantly, H3K4me3 was specifically associated 
with Fl-PHF2 (>2 fold enrichment), whereas co-precipitation of other histone 
modifications, like H3K4me2, H3K9me2 and H3K36me2 mirrored the overall 
levels in the nuclear extract (Fig. 3.9C). Thus, these results revealed that PHF2 
preferentially binds to H3K4me3 in vivo. Moreover, the enrichment of 
H3K4me3 in PHF2-associated histone H3 was impaired by mutation of tyr7, a 
residue in the PHD finger that is expected to be required to bind to H3K4me3 
(Fig. 3.9D). As a control, the JmjC domain mutant PHF2-H249A showed 
similar affinity for H3K4me3 as the wildtype protein. Genome-wide analysis 
has shown that H3K4me3 is associated with the transcriptionally active genes. 
Consistently, H3K4me3 is associated with unmethylated, i.e. active rRNA 
genes. Thus, the specific association of PHF2 with H3K4me3 supports the view 
that PHF2 binds at transcriptionally active rDNA repeats and stimulates Pol I 
transcription. 
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Figure 3.9. PHF2 interacts with H3K4me3 via the PHD finger 
(A) PHF2 and PHF8 interact with histone H3. Nuclear extracts from 
HEK293T cells overexpressing Fl-PHF2 and Fl-PHF8 were 
immunoprecipitated with anti-Flag antibodies. 3.3% of input and 33% 
of precipitated proteins were analyzed on western blots. 
(B) PHF2 is associated with core histones. Histones co-precipitated with 
Fl-PHF2 were visualized on SDS polyacrylamide gel stained with 
Coomassie blue. One percent of input and 50% of precipitated proteins 
were assayed. 
(C) PHF2 preferentially binds to H3K4me3 in vivo. Fl-PHF2 was 
overexpressed in HEK293T cells and immunoprecipitated with anti-
Flag antibodies. The co-precipitated histones and histones in the input 
samples were analyzed by immunoblotting using the indicated histone 
antibodies. 0.1% of input and 8% of precipitated proteins were analyzed 
on western blots. After normalization of the levels of histone H3, the 
relative enrichment of individual modifications in PHF2-bound histone 
H3 was shown on the right bar diagram.  
(D) PHF2 binds to H3K4me3 via the PHD finger. HEK293T cells were 
transfected with constructs encoding Fl-PHF2, Fl-PHF2H249A and Fl-
PHF2Y7A. Nuclear extracts from these cells were precipitated with 
anti-Flag antibodies, and bound proteins were analyzed by 
immunoblotting using anti-H3K4me3 antibodies. 0.5% of input and 
13% of precipitated proteins were assayed by immunoblotting. 
 
                                                                                                                             Results  
        61                                                                                                                                              
3.9. PHF8 demethylates H3K9me2 and H3K9me1  
 
The data presented so far revealed that activation of rDNA transcription by 
PHF2 and PHF8 requires the functional JmjC domain, suggesting that both 
proteins function as lysine demethylases (KDMs) in the regulation of Pol I 
transcription. Recently, it has been shown that JmjC domain-containing proteins 
can remove methyl groups from different lysine residues on histone H3, such as 
K4, K9, K27 and K36 in an iron- and αKG-dependent manner (Tsukada et al. 
2006; see review Cloos et al. 2008). Therefore, it was investigated whether 
PHF2 and PHF8 are capable to demethylate histones. First, the JmjC domains of 
PHF2 and PHF8 were aligned to two closely related lysine demethylases, 
KDM2A and KDM2B. KDM2A is capable to demethylate H3K36me2 
(Tsukada et al. 2006), and KDM2B has been shown to target both H3K36me2 
and H3K4me3 (He et al. 2008; Frescas et al. 2007; Tzatsos et al. 2009). As 
shown in Fig. 3.10A, the alignment shows that the three iron-binding and two 
αKG-binding residues in the JmjC domain of PHF8 are identical to KDM2A 
and KDM2B, suggesting that PHF8 is very likely a histone demethylase, too. 
These critical residues are also conserved in PHF2, except that a histidine is 
replaced by tyrosine at the third iron-binding residue within the JmjC domain 
(Fig. 3.10A).  
Having shown that PHF8 augments rDNA transcription, we reasoned 
that the enzymatic activity of PHF8 might remove the repressive methyl groups 
from H3K9me. To test this, PHF8 was depleted in HEK293T cells by siRNA 
and changes in histone methylation at the rDNA promoter were monitored by 
ChIP assays. Notably, depletion of PHF8 in HEK293T cells increased the levels 
of H3K9me2 by 40% and H3K9me1 by 30% (Fig. 3.10B). In accord with an 
increase in the levels of H3K9me2 and H3K9me1 (H3K9me1/2), H3K9me3 
levels were decreased. No significant change of another repressive mark, 
H4K20me3, was detected upon knockdown of PHF8. These results 
demonstrated that PHF8 is capable to specifically demethylate H3K9me2 and 
H3K9me1 at the rDNA promoter. Concomitant with an increase in H3K9me1/2 
levels upon PHF8 depletion, H3K4me3 at the rDNA promoter decreased, 
suggesting that PHF8 might mediate a crosstalk between these repressive and 
active histone marks.  
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Figure 3.10. PHF8 demethylates H3K9me2 and H3K9me1 at rDNA 
(A) Alignment of the JmjC domains of human PHF2 (aa 197-353), human PHF8 (aa 195-
351), human KDM2A (aa 148-316) and human KDM2B (aa 178-346). The predicted Fe(II)-
binding (red) and αKG-binding residues (blue) are highlighted. Substitution of histidine to 
tyrosine in the third Fe(II)-binding residue of the JmjC domain of PHF2 is indicated by a 
triangle.  
(B) PHF8 demethylates H3K9me2 and H3K9me1 at rDNA. Chromatin from HEK293T cells 
transfected with either control siRNA (light bars) or siRNA against PHF8 (grey bars) was 
precipitated with the indicated histone antibodies. The precipitated DNA was analyzed by 
qPCR with primers covering the rDNA promoter. The western blot image below shows the 
levels of cellular PHF8 and tubulin upon siRNA transfection. Error bars represent standard 
deviation of three independent experiments. 
(C) PHF2 does not demethylate H3K9me at rDNA. Chromatin from HEK293T cells 
transfected with either empty vector (pSuperior) (light bars) or plasmid encoding shRNA 
against PHF2 (dark bars) was precipitated with indicated histone antibodies. The precipitated 
DNA was analyzed by qPCR with primers covering the rDNA promoter. The western blot 
below shows the levels of cellular PHF2 and tubulin upon transfection. The data are from 
three independent experiments. 
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Like PHF8, PHF2 activates Pol I transcription in a JmjC domain-
dependent manner. Therefore, I tested whether PHF2 is also capable to 
demethylate histones at rDNA. For this, PHF2 was depleted in HEK293T cells 
by transfection of a plasmid DNA encoding a small hairpin RNA (shRNA) that 
specifically targets PHF2 and changes in histone methylations at the rDNA 
promoter were monitored in ChIP assays. In contrast to knockdown of PHF8, 
depletion of PHF2 did not increase but rather decreased the levels of both 
H3K9me1 and H3K9me2 at the rDNA promoter, whereas no significant change 
of H3K9me3 and H4K20me3 was detected (Fig. 3.10C). Likewise, no increase 
in the levels of H3K27 and H3K36 methylation at rDNA was observed in 
PHF2-depleted cells (data not shown). Thus, PHF2 does not seem to activate 
Pol I transcription by changing H3K9 methylation at the rDNA promoter. In 
agreement with this, recombinant PHF2 did not exhibit histone demethylation 
activity in vitro (personal communication M, Yonezawa). However, upon 
knockdown of PHF2, the level of H3K4me3 at the rDNA promoter dropped to a 
similar level as in PHF8-depleted cells, demonstrating that both enzymes are 
required to maintain euchromatic state of actively transcribed rRNA genes.  
 
3.10. Association of PHF2 with rDNA depends on PHF8 
 
Given that both PHF2 and PHF8 localize to nucleoli, bind to active rRNA genes 
and stimulate Pol I transcription, these two enzymes might work in concert to 
facilitate rDNA transcription. To examine the functional relationship between 
PHF2 and PHF8, the interaction of these two proteins was monitored. Co-
immunoprecipitation experiments in HEK293T cells showed that significant 
amounts of PHF8 were co-precipitated with Fl-PHF2 (Fig. 3.11A, left panel). In 
agreement with this, PHF2 could also be co-immunoprecipitated with V5-PHF8 
(Fig. 3.11A, right panel). Thus, PHF2 and PHF8 interact in vivo, suggesting that 
both enzymes may be part of a multiprotein complex that activates rDNA 
transcription. 
To gain further insight into the functional link between PHF2 and 
PHF8, either PHF2 or PHF8 was depleted in cells and the association of each 
protein with rDNA was examined by ChIP assays. As no antibody is available 
that immunoprecipitates endogenous PHF2 in ChIP assays, the association of 
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PHF2 with rDNA was monitored by overexpression of HA-PHF2 in HEK293T 
cells and precipitation with anti-HA antibodies. Notably, binding of HA-PHF2 
to the rDNA promoter and the 28S rRNA coding region was decreased by 60% 
upon depletion of PHF8, whereas depletion of PHF2 did not reduce but rather 
increased the association of PHF8 with rDNA (Fig. 3.11B and Fig. 3.11C). The 
changes in rDNA occupancy were not due to differences in protein amounts 
because the level of cellular HA-PHF2 was not affected by knockdown of 
PHF8. Likewise, depletion of PHF2 did not change the level of PHF8. 
Therefore, these results demonstrated that PHF8 is required for the recruitment 
of PHF2 to rDNA.  
 
 
Figure 3.11. Association of PHF2 with rDNA depends on PHF8  
(A) PHF8 interacts with PHF2 in vivo. Nuclear extracts from HEK293T cells 
overexpressing Fl-PHF2 or V5-PHF8 were incubated with anti-Flag or anti-V5 
antibodies, respectively. Two percent of input and 30% of precipitated proteins were 
analyzed on western blots with indicated antibodies. 
(B) Knockdown of PHF8 dissociates PHF2 from rDNA. The binding of PHF2 to the 
rDNA promoter and the 28S rRNA coding region in PHF8-depleted HEK293T cells 
was examined by ChIP assays. The western blot image at the right shows the levels of 
cellular PHF8, HA-PHF2 and tubulin upon siRNA knockdown.   
(C) Knockdown of PHF2 enhances the association of PHF8 with rDNA. The binding 
of PHF8 to rDNA was analyzed by ChIP assays in PHF2-depleted HEK293T cells. 
The western blot image at the right shows the levels of cellular PHF2, PHF8 and 
tubulin upon siRNA knockdown. 
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3.11. PHF2 and PHF8 dissociate from rDNA upon cellular 
stress 
 
Transcription of rRNA genes by Pol I is highly regulated to be responsive to 
specific environmental challenges, such as oxidative and ribotoxic stress. 
Having shown that both PHF2 and PHF8 are positive regulators of rDNA 
transcription, they may serve a role in confering environmental cues to the Pol I 
transcription machinery. Stress-induced signaling has been shown to repress 
rDNA transcription by inactivation of the Pol I-specific transcription factor TIF-
IA (Mayer et al. 2005). However, it is not yet known whether cellular stress 
may also lead to alterations of the chromatin structure of rDNA. To examine 
whether PHF2 and PHF8 are involved in stress-dependent regulation or rRNA 
synthesis, the association of both proteins with rDNA was monitored upon 
cellular stress. For this, HEK293T cells were treated with anisomycin, a 
ribotoxic drug which inhibited pre-rRNA synthesis about 60% (Fig. 3.12A). 
Cross-linked chromatin from mock- or anisomycin-treated cells was 
precipitated with antibodies against HA-PHF2 and PHF8, and co-precipitated 
DNA was analyzed by qPCR using primers amplifying the rDNA promoter and 
the 28S rRNA coding region (Fig. 3.12B). In parallel, rDNA occupancy of Pol I 
and UBF were monitored. Consistent with anisomycin-dependent inhibition of 
rDNA transcription, the association of Pol I with rDNA was significantly 
impaired, whereas binding of UBF was not affected. Notably, the association of 
PHF2 and PHF8 with the rDNA promoter and the 28S rRNA coding region was 
reduced about 40% after anisomycin treatment, although that protein levels 
remained unaffected (Fig. 3.12C). These results suggested that the association 
of PHF2 and PHF8 with rDNA is regulated by stress signaling. In addition, the 
finding that stress-dependent release of PHF2 and PHF8 being comparable to 
the dissociation of Pol I from rDNA suggests that Pol I might regulate the 
recruitment of both proteins to rDNA.  
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Fig. 3.12. The association of PHF2 and PHF8 with 
rDNA is regulated by cellular stress 
(A) Anisomycin treatment represses pre-rRNA synthesis. 
HEK293T cells were treated with anisomycin (10 mM, 2 hr). 
Pre-rRNA levels were quantified by qRT-PCR and 
normalized to β-actin mRNA levels. The data are from three 
independent experiments. 
(B) Anisomycin treatment impairs the association of PHF2 
and PHF8 with rDNA. The bar diagrams show results from 
ChIP assays comparing rDNA occupancy of Pol I, UBF, HA-
PHF2 and PHF8 in anisomycin-treated and DMSO-treated 
HEK293T cells. Error bars represent standard deviation from 
three independent experiments. 
(C) Anisomycin treatment does not change protein levels of 
Pol I, UBF, HA-PHF2 and PHF8. HEK293T cells 
ovexpressing HA-PHF2 were treated with anisomycin. Protein 
levels were monitored on western blots with the indicated 
antibodies. 
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3.12. A disease-related PHF8 mutant does not localize to 
nucleoli and activate rDNA transcription 
 
3.12.1. The JmjC domain of PHF8 is mutated in XLMR patients 
 
Recently, PHF8 has been shown to be involved in X-linked mental retardation 
(XLMR) Siderius type, a syndrome with manifest mild to borderline mental 
retardation with or without cleft lip/cleft palate (Siderius et al. 1999; 
Laummonier et al. 2005). Thus far, four mutations in PHF8 have been 
identified in XLMR patients (Laummonier et al. 2005; Abidi et al. 2007; 
Koivisto et al. 2007). Intriguingly, all these mutations are linked to the JmjC 
domain, with one point mutation changing phenylalanine to serine  (F279S) and 
three truncation mutations which either partly or completely delete this domain 
(Fig. 3. 13A). The deletion of critical residues within the JmjC domain that are 
required for the binding of the cofactor like iron and αKG in these XLMR-
associated mutants demonstrates that they are defective of histone demethylase 
activity. Thus, these observations suggested that a defect in the JmjC domain 
abolishing the lysine demethylation activity of PHF8 is detrimental and might 
be a common cause of XLMR associated with PHF8 mutation.  
 
3.12.2. F279S mutation of PHF8 abrogates its nucleolar function 
 
Notably, residue F279 is evolutionally conserved in PHF8 from vertebrates 
including human, dog, mouse and zebrafish but not in closely related JmjC 
domain-containing proteins, such as PHF2, KDM2A, KDM2B, indicating that it 
might confer a PHF8-specific function (Fig. 3.13B). Given that the XLMR 
phenotype is associated with a point mutation at position 279, this mutation has 
propably inactivated the demethylase activity of PHF8. If this was true, this 
mutant should compromise PHF8-dependent activation of rDNA transcription. 
Indeed, overexpression of PHF8-F279S in HEK293T cells did not enhance 
transcription from Pol I reporter plasmids and from endogenous rRNA genes 
(Fig. 3.13C). Moreover, in contrast to mutations within the PHD finger (Y7A) 
or on different positions within the JmjC domain (HID), GFP-PHF8-F279S 
 
                                                                                                                             Results  
        68                                                                                                                                              
 
Figure 3.13. F279S mutation impairs the nucleolar function of PHF8  
(A) Schemes show the wildtype PHF8 and four mutant PHF8 identified in XLMR patients. 
The numbers represent the position of amino acid. 
(B) (Upper panel) Alignment of the amino acid sequences of PHF8 from human (H.s.), dog 
(C.l.), mouse (M.m.) and zebrafish (D.r.) showing the coservation of residue F279. The lower 
panel shows alignment of amino acid sequences around residue F279 of human PHF8, PHF2, 
KDM2A and KDM2B.  
(C) PHF8-F279S does not activate rDNA transcription. HEK293T cells were transfected with 
expression vectors encoding Fl-PHF8 and Fl-PHF8-F279S (middle panel), or together with a 
Pol I-specific reporter plasmid (pHrP2-BH) (upper panel). The synthesis of reporter transcripts 
and pre-rRNA was monitored by qRT-PCR and normalized to β-actin mRNA levels. The 
western blot below shows the expression levels of Flag-tagged wildtype and mutant PHF8.  
(D) GFP-PHF8-F279S does not localize to nucleoli. U2OS cells overexpressing GFP-tagged 
wild type and XLMR-associated mutant F279S were immunostained with anti-UBF 
antibodies. Images of phase contrast and DNA staining with Hoechst are shown in first two 
panels.  
(E) F279S mutation impairs the association of PHF8 with the Pol I transcription machinery. 
Nuclear extracts from HEK293T cells expressing V5-PHF8 or V5-PHF8-F279S were 
precipitated with antibodies against Pol I and UBF, and the preciptated proteins were 
monitored by immunoblotting. As a control, equivalent amounts of lysates containing V5-
PHF8 and V5-PHF8-F279S were mixed and incubated with the control human IgGs. One 
percent of input and 65% of precipitated proteins were assayed on western blots. 
 
                                                                                                                             Results  
        69                                                                                                                                              
localized to nuclei but was excluded from nucleoli, indicating that the F279S 
mutation has impaired targeting of PHF8 to nucleoli (Fig. 3.13D). Significantly, 
mutation of F279 severely compromised the interaction between PHF8 and the 
Pol I transcription machinery (Fig. 3.13E), providing a molecular explanation 
for its incapability to promote Pol I transcription and its mislocalization. Thus, 
these results implicate that impairment of the nucleolar function of PHF8 may 
be responsible for the development of XLMR. 
 
3.13. PHF8 interacts with the histone H3K4 methyltransferase 
MLL1  
 
Knockdown of PHF8 causes a reduction of H3K4me3 at the rDNA promoter 
(Fig. 3.10B), indicating that PHF8 regulates H3K4 methylation. It is known that 
H3K4 is methylated by several histone methyltransferases including MLL1 that 
has been reported to localize within nucleoli (Caslini et al. 2000). To examine if 
there is a functional link between PHF8 and MLL1, the interaction between 
both proteins was analyzed. For this, MLL1 was immunoprecipitated from 
HEK293T cells expressing V5-PHF8. As shown in Fig. 3.14A (upper panel), 
V5-PHF8 was co-precipitated with MLL1, suggesting that PHF8 interacts with 
MLL1 in vivo. MLL1 is known to form a multiprotein complex comprising 
several core components, e.g. WDR5, RBBP5, and ASH2L (Shilatifard 2008). 
WDR5 has been shown to mediate the enzyme-substrate interaction by binding 
to H3K4me2 and to be required for the complex integrity (Wysocka et al. 2005; 
Dou et al. 2006). To examine whether PHF8 is capable to interact with other 
subunits of MLL1 complex, the interaction between PHF8 and WDR5 was 
monitored. As shown in Fig. 3.14A (middle panel), Fl-PHF8 was co-
precipitated with V5-WDR5. Likewise, Fl-WDR5 could be co-
immunoprecipitated with V5-PHF8 (Fig. 3.14A, lower panel). Thus, PHF8 
interacts with both MLL1 and WDR5, indicating that PHF8 is associated with 
MLL1 complex. The association of PHF8 with MLL1 suggests a cooperative 
action of MLL1 and PHF8, MLL1 establishing the active mark H3K4me3 and 
PHF8 removing the repressive H3K9 methylation. 
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Figure 3.14. PHF2 and PHF8 interact with the histone H3K9 or 
H3K4 methyltransferases 
(A) PHF8 interacts with MLL1 and WDR5. (Upper panel) Nuclear extracts 
from HEK293T cells overexpressing V5-PHF8 were incubated with anti-
MLL1 antibodies or control rabbit IgGs. Two percent of input and 65% of 
precipitated proteins were analyzed on western blots. (Middle panel) Nuclear 
extracts from HEK293T cells overexpressing V5-WDR5 and Fl-PHF8 were 
incubated with anti-V5 antibodies. One percent of input and 65% of 
precipitated proteins were monitored by immunoblotting. (Lower panel) 
Nuclear extracts from HEK293T cells overexpressing V5-PHF8 and Fl-
WDR5 were incubated with anti-V5 antibodies. One percent of input and 65% 
of precipitated proteins were analyzed on western blots. 
(B) PHF2 interacts with G9a and GLP in vivo. HEK293T cells were co-
transfected with expression vectors encoding V5-PHF2, V5-PHF8, and 
different tagged H3K9 methyltransferases, i.e. Flag-tagged G9a, GLP, 
SETDB1 and Myc-tagged SUV39H1. Nuclear extracts from these cells were 
precipitated with anti-V5 antibodies, and 2% of input and 50% of precipitated 
proteins were analyzed on western blots with the indicated antibodies. The 
heavy chain of IgGs is indicated by an asterisk. 
 
 
 
 
                                                                                                                             Results  
        71                                                                                                                                              
3.14. PHF2 interacts with the histone H3K9 methyltransferase 
G9a and GLP 
 
The finding that depletion of PHF2 leads to a decrease of H3K9me1/2 levels at 
the rDNA promoter suggests that PHF2 regulates H3K9 methylation. 
Methylation of H3K9 in heterochromatin is mediated by the histone 
methyltransferases SETDB1 and SUV39H1, whereas G9a and GLP are the 
enzymes responsible for H3K9 methylation in euchromatin. It was examined 
whether PHF2 interacts with any of these histone H3K9 methyltransferases. The 
association of PHF8 with these methyltransferases was monitored in parallel. 
For this, HEK293T cells were co-transfected with expression plasmids encoding 
V5-PHF2 or V5-PHF8 together with four different histone H3K9 
methyltransferases (Flag-tagged G9a, GLP, SETDB1 and Myc-tagged 
SUV39H1), and lysates were incubated with anti-V5 antibodies. Co-
immunoprecipitation of the respective methyltransferases with V5-PHF2 or V5-
PHF8 was monitored on immunoblots. As shown in Fig. 3.14B, V5-PHF2 was 
co-precipitated with Fl-G9a and Fl-GLP, which is consistent with the finding 
that GLP and G9a form a heteromeric complex (Tachibana et al. 2005). In 
contrary, no clear association of Fl-SETDB1 and Myc-SUV39H1 with V5-
PHF2 was observed. Thus, PHF2 interacts with the euchromatic histone H3K9 
methyltransferases G9a and GLP, but not with the heterochromatic histone 
H3K9 methyltransferases SETDB1 and SUV39H1. Given that G9a-mediated 
methylation of H3K9 is required for rDNA transcription (Yuan et al. 2007), the 
association of PHF2 with G9a suggests that PHF2 might facilitate G9a to 
stimulate rDNA transcription. On the other hand, no clear interaction of V5-
PHF8 with any of the tested histone H3K9 methyltransferases was observed 
(Fig. 3.14B). This data is consistent with the finding that PHF8 is associated 
with the histone H3K4 methyltransferase MLL1 complex and demethylates 
H3K9me1/2.  
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3.15. PHF2 interacts with the nucleosome remodeling and 
deacetylase complex NuRD 
 
To further analyze the function of PHF2 on nucleolar chromatin, its association 
with other chromatin modifying enzymes was examined. For this, Fl-PHF2 was 
overexpressed and immunoprecipitated from HEK293T cells, and co-
precipitated proteins were analyzed. As shown in Fig. 3.15A, two enzymatic 
components of the nucleosome remodeling and deacetylase complex NuRD, 
Mi2β and HDAC1, were found to be co-precipitated with Fl-PHF2, suggesting 
PHF2 is associated with NuRD complex in vivo. Interestingly, the ATP-
dependent chromatin remodeler Mi2β has been shown to be associated with 
rDNA and to stimulate Pol I transcription (Shimono et al. 2005). Therefore, 
PHF2 might act in concert with NuRD complex to promote rRNA synthesis. If 
PHF2 interacts with NuRD complex, a subpopulation of PHF2 and NuRD 
complex should be associated in cell extracts. To test this, nuclear extract from 
HEK293T cells was loaded onto 12.5%-30% glycerol gradient and subjected to 
ultracentrifugation. Fractions were collected after centrifugation and the 
distribution of PHF2 and two subunits of NuRD complex, Mi2β and HDAC1 in 
these fractions was analyzed on western blots. Importantly, PHF2 co-peaked 
with Mi2β and HDAC1 at fraction 15 and 16 (Fig. 3.15B). The co-
sedimentation of PHF2 with Mi2β and HDAC1 demonstrated that a significant 
portion of cellular PHF2 is associated with NuRD complex in a multiprotein 
complex, indicating that they might function as a complex to activate rDNA 
transcription via modulating the chromatin structure of rDNA.  
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Figure 3.15. PHF2 interacts with NuRD complex 
(A) PHF2 interacts with Mi2β and HDAC1 in vivo. 
Nuclear extract from HEK293T cells overexpressing Fl-
PHF2 was incubated with anti-Flag antibodies. Two 
percent of input and 30% of precipitated proteins were 
analyzed on western blots using indicated antibodies. 
(B) PHF2 cosediments with Mi2β and HDAC1 in 
glycerol gradient. Nuclear extract (0.38 mg) from 
HEK293T cells was loaded on 12.5%-30% glycerol 
gradient. After ultracentrifugation (45,000 rpm/17 
hr/4oC), proteins were collected in 21 fractions, TCA 
precipitated and analyzed by immunoblotting using 
indicated antibodies. The arrowhead indicats the break 
point between two separated SDS-gels. 
 
 
3.16. PHF2 and KDM2B compete for rDNA occupancy 
 
Recently, the JmjC domain-containing protein KDM2B has been reported to 
localize to nucleoli and to repress rDNA transcription via demethylation of the 
active histone mark H3K4me3 (Frescas et al. 2007). To reproduce these 
observations, nucleolar localization and rDNA occupancy of KDM2B were 
examined. Indirect immunofluorescence assays shown in Fig. 3.16A revealed 
that Flag-tagged KDM2B (Fl-KDM2B) localized to nucleoli and co-stained 
with UBF in U2OS cells. Consistent with KDM2B localizing to nucleoli and 
binding to rDNA, ChIP assays performed in HEK293T cells demonstrated that 
V5-tagged KDM2B (V5-KDM2B) was equally distributed at all rDNA regions 
tested, including the enhancer region, the rDNA promoter, the pre-rRNA coding 
region and intergenic spacer (Fig. 3.16B).  
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Figure 3.16. KDM2B localizes to nucleoli and binds to rDNA 
(A) Fl-KDM2B colocalizes with UBF in nucleoli. U2OS cells overexpressing Fl-
KDM2B were immunostained with anti-Flag-Cy3 and anti-UBF antibodies. Images of 
phase contrast and DNA staining with Hoechst are shown in the first two panels.  
(B) KDM2B is associated with rDNA. Cross-linked chromatin from HEK293T cells 
overexpressing V5-KDM2B or mock-transfected was incubated with anti-V5 antibodies 
and precipitated DNA was amplified by qPCR using primers encompassing different 
regions of rDNA repeats indicated in the scheme below. 
 
The observation that PHF2, PHF8 and KDM2B are present in nucleoli 
and regulate rDNA transcription raises the question about the functional 
relationship among these three JmjC domain-containing proteins. To examine 
whether these three nucleolar lysine demethylases physically interact, the 
interaction of KDM2B with PHF2 and PHF8 was examined by co-
immunoprecipitation assays in HEK293T cells. As shown in Fig. 3.17 (left and 
middle panel), V5-KDM2B was co-precipitated with both Fl-PHF2 and Fl-
PHF8. Consistently, both V5-PHF2 and V5-PHF8 could be co-precipitated with 
Fl-KDM2B (Fig. 3.17, right panel). Thus, KDM2B interacts with PHF2 and 
PHF8 in vivo.  
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Figure 3.17. KDM2B interacts with PHF2 and PHF8 
HEK293T cells were transfected with expression constructs encoding V5-KDM2B and 
Fl-PHF2 (left panel) or Fl-PHF8 (middle panel). Nuclear extracts from these cells were 
incubated with anti-Flag antibodies, and 2% of input and 33% of precipitated proteins 
were assayed by immunoblotting. (Right panel) HEK293T cells were transfected with 
expression plasmids encoding Fl-KDM2B, V5-PHF2 and V5-PHF8. Nuclear extracts 
from these cells were incubated with anti-Flag antibodies, and 2% of input and 33% of 
precipitated proteins were assayed on western blots.   
 
To further explore the functional link among KDM2B, PHF2 and 
PHF8 at rDNA, KDM2B was depleted in HEK293T cells via siRNA and rDNA 
occupancy of PHF2 and PHF8 was examined by ChIP assays. As shown in Fig. 
3.18A, the mRNA level of KDM2B was reduced by about 60% upon 
transfection of KDM2B-specific siRNA. Notably, the association of PHF2 with 
the rDNA promoter and the pre-rRNA coding region was enhanced >2- fold 
upon knockdown of KDM2B. The association of PHF8 with rDNA was also 
augmented, although to a lesser extent compared to PHF2 (Fig. 3.18A). The 
changes of rDNA occupancy of PHF2 and PHF8 were not due to the different 
levels of both proteins upon knockdown of KDM2B, as shown by western blot 
analysis. Thus, depletion of KDM2B leads to an increased association of PHF2 
and PHF8 with rDNA, suggesting that a competition mechanism exists among 
KDM2B, PHF2 and PHF8 for rDNA occupancy. If so, depletion of PHF2 and 
PHF8 should enhance the association of KDM2B with rDNA. Indeed, depletion 
of PHF2 significantly enhanced rDNA occupancy of V5-KDM2B (Fig. 3.18B), 
but not the expression level of V5-KDM2B. However, no increase of rDNA 
occupancy of V5-KDM2B, but rather a slightly decrease, was observed upon 
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knockdown of PHF8, suggesting that PHF2, but not PHF8 is the direct 
competitor of KDM2B for rDNA occupancy. The competition between a 
transcriptional activator PHF2 and a repressor KDM2B indicates that PHF2 
may partly activate rDNA transcription by replacing a repressor from rDNA. 
 
 
Figure 3.18. KDM2B competes with PHF2 for rDNA occupancy 
(A) Knockdown of KDM2B augments the binding of PHF2 and PHF8 to rDNA. 
The binding of PHF2 and PHF8 to the rDNA promoter and the pre-rRNA coding 
region was monitored by ChIP assays with chromatin from HEK293T cells 
transfected with KDM2B-specific siRNA (dark bars) or the control non-target 
siRNA (light bars). qRT-PCR result at the left panel shows the level of KDM2B 
mRNA after normalizing to β-actin mRNA levels upon siRNA transfection. The 
western blot image at the right panel shows the levels of HA-PHF2 and PHF8 
after siRNA transfection. 
(B) Depletion of PHF2, but not PHF8 enhances the association of KDM2B with 
rDNA. The binding of V5-KDM2B to rDNA was monitored by ChIP assays 
using anti-V5 antibodies with chromtin from HEK293T cells depletion of PHF2 
(left panel) or PHF8 (middle panel). The western blot image at the right panel 
shows the levels of V5-KDM2B and tubulin upon siRNA knockdown. 
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4.  Discussion 
 
The transcriptional activity of rRNA genes is reflected by specific euchromatic 
and heterochromatic modifications. Acetylation of histone H4 and methylation 
of H3K4 are characteristic for transcribed rRNA genes, whereas DNA 
hypermethylation at CpG residues, histone H4 hypoacetylation, and methylation 
of H3K9 and H4K20 correlate with transcriptional silencing (Santoro et al. 
2002; Zhou et al. 2002). The ATP-dependent chromatin remodeling complex, 
NoRC, coordinates the activities of enzymes that modify histones and methylate 
DNA to establish a ‘‘closed’’ heterochromatic state (Santoro and Grummt 
2005). In contrast to NoRC-dependent silencing, little is known about the 
mechanisms that establish and maintain the euchromatic state of active rDNA 
repeats. The recently identified histone demethylases are likely to play a crucial 
role, since they are able to remove the inhibitory methylation marks on histone 
H3. In the present work, the function of two putative JmjC domain-containing 
histone demethylases PHF2 and PHF8, which localize within nucleoli, has been 
studied. The results reveal that PHF2 and PHF8 function in a coordinated 
manner to maintain the euchromatic state of active rRNA genes. 
 
4.1.  PHF2 and PHF8 are targeted to active rDNA 
 
Both endogenous and GFP-tagged PHF2 and PHF8 localize to nucleoli, 
suggesting that both proteins serve a role in regulation of nucleolar chromatin 
function and/or rDNA transcription. Indeed, protein-protein interaction 
experiments showed that PHF2 and PHF8 interact with Pol I and with UBF, a 
Pol I-specific transcription factor. This data suggests that the nucleolar 
localization of PHF2 and PHF8 is probably mediated by association with the 
Pol I transcription machinery. In support of this, a point mutant (PHF8-F279S) 
that does not interact with Pol I and UBF does not localize in nucleoli (Fig. 
3.13C). On the other hand, PHF2 and PHF8 are also associated with 
untranscribed intergenic spacer (Fig. 3.3B) and therefore additional recruitment 
mechanisms should exist that facilitate the association of PHF2 and PHF8 with 
rDNA. The interaction of PHF2 and PHF8 with histones may explain the 
presence of both proteins at intergenic spacer that is compacted by nucleosomes 
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in both active and silent rDNA repeats. DNA methylation assays of PHF2 and 
PHF8-associated rDNA revealed that both proteins preferentially bind to 
unmethylated, active rRNA genes (Fig.  3.3C), which are characterized by the 
active histone mark H3K4me3. In vitro binding assays showed that the PHD 
fingers of PHF2 and PHF8 specifically bind to H3K4me3 (Fig. 3.9D and data 
not shown). Thus, the recruitment of PHF2 and PHF8 to active rDNA repeats is 
likely mediated by cooperative interaction with both Pol I and H3K4me3. The 
importance of this recruitment is underscored by the observation that mutations 
in the PHD fingers abolished PHF2 and PHF8-mediated activation of rDNA 
transcription. The targeting of PHF2 and PHF8 to active rDNA repeats reveals a 
common step-wise mechanism of recruitment of chromatin modifying enzymes 
to specific genes. First, interactions with gene specific DNA-binding factors 
recruit these enzymes to their target genes. Second, the local chromatin 
enviroment is recognized by the chromatin binding modules that are possessed 
by the enzymes themselves or by their associated proteins. With this, the 
chromatin modifying enzymes are capable to modulate chromatin in a temporal 
and spatial-dependent manner (Lan et al. 2008). For instance, the H3K4me3 
demethylase SMCX/KDM5C (also known as JARID1C) has been shown to be 
associated with the sequence-specific REST complex, which targetes KDM5C 
to REST responsible genes. The PHD finger of KDM5C recognizes the 
repressive mark H3K9me3, which may provide additional selectivity for its 
recruitment. The coordinated action of the PHD finger and JmjC domain of 
KDM5C leads to repression of neuronal genes in non-neuronal tissues (Iwase et 
al. 2007; Tahiliani et al. 2007).  
The association of PHF2 with rDNA was significantly reduced upon 
depletion of PHF8 (Fig. 3.11B). In contrast, depletion of PHF2 did not impair 
rDNA occupancy of PHF8 (Fig. 3.11C). This data indicates that PHF8 is 
required for the recruitment of PHF2. Knockdown of PHF8 resulted in a 
decrease of H3K4me3 and an increase of H3K9me1/2 at rDNA (Fig. 3.10B). 
Thus, these results suggested that the association with H3K4me3 facilitates 
binding of PHF2 to rDNA. The presence of H3K9me1/2, however, appears to 
be inhibitory for binding of PHF2 to rDNA. Therefore, PHF2 may serve as an 
auxiliary factor that cooperates with PHF8 to stimulate rDNA transcription. 
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4.2.  PHF8 demethylates H3K9me1/2 at active rRNA genes 
 
Consistent with a positive role in rDNA transcription, depletion of PHF8 
increased the levels of the repressive marks H3K9me2 and H3K9me1 
(H3K9me1/2) at the rDNA promoter (Fig. 3.10B), suggesting that PHF8 
demethylates H3K9me1/2. In accord with this, in vitro demethylation assays 
revealed that PHF8 (1-690) purified from baculovirus-infected Sf9 insect cells 
demethylated H3K9me1 and H3K9me2 (personal communication 
M.Yonezawa). The JmjC domain-deficient mutant PHF8-HID was inactive in 
these assays, underscoring the specificity of the demethylation reaction. Given 
that the PHD finger of PHF8 interacts with H3K4me3, it was examined whether 
the presence of H3K4me3 may stimulate demethylation of H3K9me2. For this, 
a doubly modified histone H3 peptide that is trimethylated at lysine 4 and 
dimethylated at lysine 9 (H3K4me3/K9me2) was used as substrate for the 
demethylation assays. Coversion of H3K9me2 to mono- or unmodified form by 
PHF8 was markedly enhanced if the H3K4 was trimethylated. A point mutation 
in the PHD finger (PHF8-Y7A) that abolishes the interaction with H3K4me3 
suppressed the stimulatory effect of H3K4me3 on PHF8-mediated 
demethylation of H3K9me2. This data indicates that binding of the PHD finger 
of PHF8 to H3K4me3 promotes demethylation of H3K9me2. The finding that 
demethylation of H3K9 depends on the presence of adjacent H3K4me3 
underscores the cross-talk of histone modifications in chromatin-based 
processes. It has been demonstrated that the addition or removal of certain 
modifications may be dependent upon other existing modifications (Jenuwein 
and Allis 2001). This can occur both in cis, from within the same histone, or in 
trans, contributed from another histones. Consistently, a point mutation next to 
the PHD finger of the H3K4me3 demethylase SMCX/KDM5C has been shown 
to impair both the association of the PHD finger with H3K9me3 and the 
demethylase activity in vitro (Iwase et al. 2007). Moreover, the histone 
demethylase KDM4A contains a double tudor domain that is capable to 
recognize H3K4me2/3 and H4K20me2/3 (Kim et al. 2006), suggesting that 
stimulation of demethylase activity by pre-existing methylation marks may be a 
common mechanism for KDMs that contain methyl-lysine binding motifs. 
Mammalian cells containing 400 copies of rRNA genes, about half of 
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them being actively transcribed. Therefore, ChIP assays monitor the average 
levels of histone marks both at active and silent rRNA genes. For this reason, 
the increase of H3K9me1/2 levels upon depletion of PHF8 can be caused by 
either inhibiting the demethylation of H3K9me1/2 at silent or active rDNA. 
Several lines of experimental evidences favor the latter possibility. First, PHF8 
binds to active rRNA genes, which is likely due to the association with both the 
Pol I transcription machinery and H3K4me3. Second, in vitro demethylation 
assays reveal that H3K4me3 is required for efficiently removing H3K9me1/2 by 
PHF8. H3K4me3 is exclusively associated with active rRNA genes, whereas 
H3K9 methylation is present at both active and silent rDNA (Yuan et al. 2007). 
Third, depletion of PHF8 reduced the level of H3K4me3 at the rDNA promoter, 
suggesting a functional link between demethylation of H3K9me1/2 and 
trimethylation of H3K4. The association of PHF8 with the histone H3K4 
methyltransfearse MLL1 complex (Fig. 3.14A) further supports the cross-talk 
between H3K4me3 and H3K9me1/2 demethylation. Taken together, PHF8 
binds to active rRNA genes and maintains the euchromatic state of 
transcriptionally active rDNA repeats.  
 
4.3.  PHF2 does not demethylate histones 
 
The finding that the JmjC domain-deficient mutant PHF2 (PHF2-H249A) does 
not activate rDNA transcription suggests that PHF2 may be an active lysine 
demethylase (Fig. 3.7A). However, depletion of PHF2 in HEK293T cells did 
not result in upregulation of any histone methylation mark tested (Fig. 3.10C 
and data not shown). In addition, recombinant PHF2 did not show any histone 
demethylation activity in vitro (personal communication M. Yonezawa). 
Therefore, PHF2 is probably not an active histone demethylase. However, it 
cannot be excluded that the point mutation (PHF2-H249A) affects the whole 
protein structure, thereby abrogating its function. If this is not the case, PHF2 
may either demethylate non-histone substrates or possess another JmjC domain-
dependent enzymatic activity rather than demethylation. A growing number of 
non-histone proteins, such as p53, TAF10 and G9a have been shown to be 
subjected to methylation at individual lysine residues (Sims et al. 2008). Similar 
to histone methylation, methylation of non-histone proteins is reversible. For 
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instance, lysine demethylase LSD1 is able to demethylate p53 at residue K370 
(Huang et al. 2007). Two lysine residues in G9a and GLP have been shown to 
be methylated by G9a and an unkown methyltransferase (Sampath et al. 2007). 
Since both G9a and GLP interact with PHF2 (Fig. 3.14B), they are potential 
demethylation substrates for PHF2. Before the histone demethylation activity of 
the JmjC domain has been identified, this domain was suggested to be 
responsible for the enzymatic activity of iron- and αKG-dependent oxygenases 
(Trewick et al. 2005). For instance, the JmjC domain-containing protein FIH is 
an asparaginyl hydroxylase that targets residue Asp 803 of HIF-1α  (Lando et 
al. 2002). Thus, it is likely that PHF2 may function as a hydroxylase.  
The alignment of the JmjC domains of PHF2, PHF8, KDM2A and 
KDM2B revealed a substitution of histidine to tyrosine in the third iron-binding 
residue (Fig. 3.10A). Intriguingly, the same substitution occurs in the S. pombe 
JmjC domain-containing protein Epe1, which renders the enzyme inactive 
towards histone substrates (Tsukada et al. 2006). However, Epe1 requires 
predicted iron- and αKG-binding residues for in vivo function, suggesting that 
the functional JmjC domain is essential (Trewick et al. 2007).  
 
4.4.  PHF2 and PHF8 antagonize KDM2B at active rDNA 
 
The maintaince of the balance of histone methylation requires the action of both 
histone methyltransferases and demethylases. PHF8 functions together with 
PHF2 at active rRNA genes to maintain them in a euchromatic state. On the 
other hand, KDM2B is capable to silence active rRNA genes by demethylating 
H3K4me3 (Frescas et al. 2007). While the distribution of KDM2B to nucleoli is 
mediated by a nucleolar localization sequence (NoLS), the binding to active 
rDNA might be conferred by a DNA-binding motif, the CXXC domain, which 
has been shown to have a strong preference for unmethylated CpG 
dinucleotides (Koyama-Nasu et al. 2007). The counteraction of PHF2, PHF8 
and KDM2B offers a mechanism how the cell regulates the chromatin state of 
active rRNA genes (Fig. 4.1). PHF2 and PHF8 are targeted to rDNA by 
interaction with Pol I and UBF, and the recognition of H3K4me3 by their PHD 
fingers offers additional selectivity for active rRNA genes. The observation that 
depletion of PHF2 enhanced rDNA occupancy of KDM2B suggested that PHF2 
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is capable to antaganize the activity of the H3K4me3 demethylase KDM2B 
(Fig. 3.18A). This antagonization mechanism prevents erasion of the active 
mark H3K4me3. Importantly, the PHF8-associated MLL1 complex 
trimethylates H3K4 and the presence of H3K4me3 stimulates demethylation of 
H3K9me1/2 by PHF8. Therefore, a complex consisting of at least 
PHF8/MLL1/PHF2 is required to maintain and propagate the epigenetically 
active state of rRNA genes. On the other hand, downregulation of rDNA 
transcription not only leads to loss of rDNA occupancy of Pol I but also of 
PHF2 and PHF8. The dissociation of PHF2 from rDNA in turn may enable 
KDM2B to bind to rDNA. The changes of association of these chromatin 
modifying enzymes will establish heterochromatic histone modifications, i.e. 
will lead to decreased H3K4me3 and increased H3K9me1/2 levels at the rDNA 
promoter. However, this model of dynamic balance between PHF2, PHF8 and 
KDM2B still needs to be experimentally validated.  
 
 
Figure 4.1. PHF2/PHF8/MLL1 and KDM2B regulate the chromatin state 
of the active rRNA genes 
PHF8 and PHF2 bind to active rDNA repeats by recognition of H3K4me3 (green balls) 
with their PHD fingers. After recruitment, PHF8 removes the repressive mark 
H3K9me1/2 at the rDNA promoter (red balls), whereas PHF2 antaganizes the 
association of the H3K4me3 demethylase KDM2B. Moreover, PHF8 is associated with 
the histone H3K4 methyltransferase MLL1-WDR5 complex. The presence of 
H3K4me3 stimulates the demethylation of H3K9me1/2 by PHF8. Therefore, the 
cooperative action of PHF2/PHF8/MLL1 establishes and maintains euchromatic 
histone modifications at active rRNA genes. Upon repression of rDNA transcription, 
PHF2 and PHF8 dissociate from rDNA, whereas KDM2B is able to bind to active 
rRNA genes and demethylates the active mark H3K4me3. As a consequence, 
heterochromatic histone modifications are established, i.e. a decreased H3K4me3 and 
increased H3K9me1/2 levels. 
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4.5.  PHF8 and XLMR 
 
X-linked metal retardation is a common cause of moderate to severe intellectual 
disability in males. XLMR is very heterogeneous and over 60 genes have been 
linked to this syndrome. A subset of these genes seems to be involved in 
regulation of chromatin structure and gene expression, which include DNA 
binding transcription factors such as ARX and ZNF41 as well as methyl-CpG 
binding protein MeCP2 and the histone demethylase SMCX/KDM5C. In 
particular, mutations in SMCX/KDM5C and PHF8 have been found in families 
with XLMR, suggesting a link between specific histone demethylases and 
human diseases. The finding that XLMR-associated SMCX/KDM5C mutations 
compromised H3K4me3 demethylation suggested that XMLR may be in part 
caused by aberrant histone methylation (Iwase et al. 2007; Tahiliani et al. 2007). 
In support of this notion, three of four identified XLMR-related PHF8 mutations 
result in partial or complete deletion of the JmjC domain, which apparently 
abrogate the demethylation activity. Moreover, an XLMR-associated point 
mutation within the JmjC domain of PHF8 (F279S) also abolished the histone 
demethylase acitivity (personal communication M. Yonezawa). This mutation 
was predicted to have a damaging influence on the function and structure of 
PHF8 (Koivisto et al. 2007), which may explain why a point mutant at a non-
cofactor binding residue abolishes the demethylation activity of PHF8. 
Importantly, this point mutation also impaired nucleolar localization and 
transcription activation of PHF8, linking XLMR to dysfunction of rRNA 
synthesis. PHF8 is not only highly expressed in early stages of brain 
development, but also in the cerebellum and hippocampus in adult brain 
(Laumonnier et al. 2005), which are vital structures for memory and learning. 
Thus, XLMR-associated mutations of PHF8 impair ribosome biogenesis, which 
might cause proliferation defects of cells involved in cognition. Howerver, it 
cannot be excluded that PHF8 might also serve non-nucleolar functions in the 
cells, whose defect due to PHF8 mutation might also contribute to the 
development of XLMR. In particular, the mutant PHF8-F279S may serve a 
dominant negative function, which bind to H3K4me3 via its PHD domain at 
promoters of certain XLMR target genes. The lack of histone demethylation 
activity of PHF8-F279S may then keep these genes in transcriptional silent 
 
                                                                                                                        Discussion 
        84                                                                                                                                              
state, which may in turn cause XLMR. Nevertheless, the present study offers a 
possible epigenetic mechanism to explain the role of PHF8 in XLMR.  
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